CA3154578A1 - Compositions et methodes de prevention et/ou de traitement de la covid-19 - Google Patents

Info

Publication number

CA3154578A1

CA3154578A1 CA3154578A CA3154578A CA3154578A1 CA 3154578 A1 CA3154578 A1 CA 3154578A1 CA 3154578 A CA3154578 A CA 3154578A CA 3154578 A CA3154578 A CA 3154578A CA 3154578 A1 CA3154578 A1 CA 3154578A1

Authority

CA

Canada

Prior art keywords

nucleic acid

protein

mol

sequence

acid vaccine

Prior art date

2022-04-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 92
• 208000025721 COVID-19 Diseases 0.000 title claims abstract description 37
• 239000000203 mixture Substances 0.000 title abstract description 105
• 238000011282 treatment Methods 0.000 title abstract description 16
• 230000002265 prevention Effects 0.000 title abstract description 14
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 claims abstract description 396
• 229940023146 nucleic acid vaccine Drugs 0.000 claims abstract description 396
• 241001678559 COVID-19 virus Species 0.000 claims abstract description 278
• 102000040430 polynucleotide Human genes 0.000 claims abstract description 261
• 108091033319 polynucleotide Proteins 0.000 claims abstract description 261
• 239000002157 polynucleotide Substances 0.000 claims abstract description 261
• 101710172711 Structural protein Proteins 0.000 claims abstract description 131
• 230000000116 mitigating effect Effects 0.000 claims abstract description 3
• -1 uracil nucleoside Chemical class 0.000 claims description 283
• 108090000623 proteins and genes Proteins 0.000 claims description 160
• 102000004169 proteins and genes Human genes 0.000 claims description 150
• 238000006467 substitution reaction Methods 0.000 claims description 101
• 150000007523 nucleic acids Chemical group 0.000 claims description 85
• 108020004414 DNA Proteins 0.000 claims description 83
• 229940096437 Protein S Drugs 0.000 claims description 79
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 78
• 101710198474 Spike protein Proteins 0.000 claims description 75
• 108020004999 messenger RNA Proteins 0.000 claims description 72
• 150000002632 lipids Chemical class 0.000 claims description 61
• 230000035772 mutation Effects 0.000 claims description 61
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 57
• 239000008194 pharmaceutical composition Substances 0.000 claims description 47
• 108020005345 3' Untranslated Regions Proteins 0.000 claims description 45
• 108020003589 5' Untranslated Regions Proteins 0.000 claims description 31
• 108020004705 Codon Proteins 0.000 claims description 31
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 30
• 239000002777 nucleoside Substances 0.000 claims description 26
• 230000037430 deletion Effects 0.000 claims description 25
• 238000012217 deletion Methods 0.000 claims description 25
• 102220642430 Spindlin-1_P681R_mutation Human genes 0.000 claims description 24
• 102200128238 rs201124247 Human genes 0.000 claims description 23
• 102220599406 Spindlin-1_N501Y_mutation Human genes 0.000 claims description 21
• 229930182558 Sterol Natural products 0.000 claims description 21
• 150000003432 sterols Chemical class 0.000 claims description 21
• 235000003702 sterols Nutrition 0.000 claims description 21
• 102220074121 rs796052019 Human genes 0.000 claims description 20
• 102220579649 ATP-dependent RNA helicase A_K417N_mutation Human genes 0.000 claims description 19
• 230000037431 insertion Effects 0.000 claims description 19
• 238000003780 insertion Methods 0.000 claims description 19
• 102220324912 rs1298953581 Human genes 0.000 claims description 17
• 102220031793 rs431825282 Human genes 0.000 claims description 17
• 102220590697 Spindlin-1_A67V_mutation Human genes 0.000 claims description 16
• 102220599659 Spindlin-1_E484A_mutation Human genes 0.000 claims description 16
• 102220036845 rs587780085 Human genes 0.000 claims description 16
• 102220087615 rs864622785 Human genes 0.000 claims description 16
• 102220599613 Spindlin-1_N679K_mutation Human genes 0.000 claims description 15
• 235000012000 cholesterol Nutrition 0.000 claims description 15
• 102220599628 Spindlin-1_L981F_mutation Human genes 0.000 claims description 14
• 102220599606 Spindlin-1_N764K_mutation Human genes 0.000 claims description 14
• 102220599641 Spindlin-1_N856K_mutation Human genes 0.000 claims description 14
• 102220599634 Spindlin-1_Q954H_mutation Human genes 0.000 claims description 14
• 102220599679 Spindlin-1_T547K_mutation Human genes 0.000 claims description 14
• 102220350121 c.1513T>C Human genes 0.000 claims description 14
• 230000028993 immune response Effects 0.000 claims description 14
• 102220249089 rs1553970560 Human genes 0.000 claims description 14
• 102220076412 rs772589363 Human genes 0.000 claims description 14
• 102220029076 rs78775072 Human genes 0.000 claims description 14
• 102220590684 Spindlin-1_T95I_mutation Human genes 0.000 claims description 13
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 13
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Natural products O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 12
• 239000002105 nanoparticle Substances 0.000 claims description 12
• 230000001965 increasing effect Effects 0.000 claims description 11
• 102200056390 rs12204826 Human genes 0.000 claims description 11
• 230000000694 effects Effects 0.000 claims description 10
• 102220020383 rs397508214 Human genes 0.000 claims description 10
• 208000024891 symptom Diseases 0.000 claims description 10
• 102220590551 Spindlin-1_G339D_mutation Human genes 0.000 claims description 9
• 230000003472 neutralizing effect Effects 0.000 claims description 9
• 229940035893 uracil Drugs 0.000 claims description 9
• 102220114694 rs763810935 Human genes 0.000 claims description 8
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 7
• 102200080054 rs121908980 Human genes 0.000 claims description 7
• 102200113705 rs72551353 Human genes 0.000 claims description 7
• 101000629318 Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein Proteins 0.000 claims description 6
• 102220599627 Spindlin-1_D950N_mutation Human genes 0.000 claims description 6
• 102220599422 Spindlin-1_L452R_mutation Human genes 0.000 claims description 6
• 102220590621 Spindlin-1_T19R_mutation Human genes 0.000 claims description 6
• 102220599418 Spindlin-1_V1176F_mutation Human genes 0.000 claims description 6
• 238000007918 intramuscular administration Methods 0.000 claims description 6
• 102200038843 rs199472766 Human genes 0.000 claims description 6
• 102220599657 Spindlin-1_Q493R_mutation Human genes 0.000 claims description 5
• 102220089738 rs147911699 Human genes 0.000 claims description 5
• 102200088972 rs1801133 Human genes 0.000 claims description 5
• 102220053106 rs199537178 Human genes 0.000 claims description 5
• NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims description 4
• 230000006698 induction Effects 0.000 claims description 4
• 102220277108 rs1553412687 Human genes 0.000 claims description 4
• 102200089032 rs1554935371 Human genes 0.000 claims description 4
• 102220330701 rs1556000154 Human genes 0.000 claims description 4
• 102220256968 rs368859380 Human genes 0.000 claims description 4
• 102220114388 rs370362589 Human genes 0.000 claims description 4
• 102220222416 rs749443090 Human genes 0.000 claims description 4
• 102220119855 rs768184220 Human genes 0.000 claims description 4
• 102220077512 rs797044926 Human genes 0.000 claims description 4
• 102200107909 rs886039483 Human genes 0.000 claims description 4
• 108090000978 Interleukin-4 Proteins 0.000 claims description 3
• 230000005867 T cell response Effects 0.000 claims description 3
• 230000001939 inductive effect Effects 0.000 claims description 3
• 102200059660 rs104894317 Human genes 0.000 claims description 3
• 102200037714 rs2655655 Human genes 0.000 claims description 3
• 102220058658 rs771746264 Human genes 0.000 claims description 3
• 210000002966 serum Anatomy 0.000 claims description 3
• 102100037850 Interferon gamma Human genes 0.000 claims description 2
• 108010074328 Interferon-gamma Proteins 0.000 claims description 2
• 108010002350 Interleukin-2 Proteins 0.000 claims description 2
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 2
• 230000036755 cellular response Effects 0.000 claims description 2
• 239000007924 injection Substances 0.000 claims description 2
• 238000002347 injection Methods 0.000 claims description 2
• 150000003904 phospholipids Chemical class 0.000 claims description 2
• 102220103674 rs147911699 Human genes 0.000 claims description 2
• 231100000673 dose–response relationship Toxicity 0.000 claims 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
• STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims 2
• 230000016784 immunoglobulin production Effects 0.000 claims 2
• 239000011521 glass Substances 0.000 claims 1
• 102200110418 rs570878629 Human genes 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 abstract description 3
• 238000002360 preparation method Methods 0.000 abstract description 2
• 230000001225 therapeutic effect Effects 0.000 abstract description 2
• 108090000765 processed proteins & peptides Proteins 0.000 description 212
• 102000004196 processed proteins & peptides Human genes 0.000 description 186
• 229920001184 polypeptide Polymers 0.000 description 156
• 235000018102 proteins Nutrition 0.000 description 119
• 239000012634 fragment Substances 0.000 description 113
• 230000004048 modification Effects 0.000 description 74
• 238000012986 modification Methods 0.000 description 74
• 125000003729 nucleotide group Chemical group 0.000 description 69
• 239000002773 nucleotide Substances 0.000 description 65
• 235000001014 amino acid Nutrition 0.000 description 62
• 150000001413 amino acids Chemical class 0.000 description 62
• 229940024606 amino acid Drugs 0.000 description 61
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 57
• 108091026890 Coding region Proteins 0.000 description 51
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 51
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 45
• 238000009472 formulation Methods 0.000 description 42
• 239000002502 liposome Substances 0.000 description 39
• 102000039446 nucleic acids Human genes 0.000 description 35
• 108020004707 nucleic acids Proteins 0.000 description 35
• 230000000670 limiting effect Effects 0.000 description 34
• 101710085938 Matrix protein Proteins 0.000 description 31
• 101710127721 Membrane protein Proteins 0.000 description 31
• 101710141454 Nucleoprotein Proteins 0.000 description 31
• 108091081024 Start codon Proteins 0.000 description 29
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 28
• 102100031673 Corneodesmosin Human genes 0.000 description 26
• 101710139375 Corneodesmosin Proteins 0.000 description 26
• 235000000346 sugar Nutrition 0.000 description 26
• FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 25
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 23
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 23
• OYHQOLUKZRVURQ-UHFFFAOYSA-M octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC([O-])=O OYHQOLUKZRVURQ-UHFFFAOYSA-M 0.000 description 22
• 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 21
• 241001553178 Arachis glabrata Species 0.000 description 19
• 230000027455 binding Effects 0.000 description 19
• 239000002245 particle Substances 0.000 description 19
• 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 18
• 210000004027 cell Anatomy 0.000 description 18
• 101710204837 Envelope small membrane protein Proteins 0.000 description 17
• 101710145006 Lysis protein Proteins 0.000 description 17
• 108091023045 Untranslated Region Proteins 0.000 description 17
• 238000003786 synthesis reaction Methods 0.000 description 17
• 108010076504 Protein Sorting Signals Proteins 0.000 description 16
• JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 16
• 229960005486 vaccine Drugs 0.000 description 16
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 15
• 125000000539 amino acid group Chemical group 0.000 description 15
• 230000015572 biosynthetic process Effects 0.000 description 15
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 15
• 230000014616 translation Effects 0.000 description 15
• 238000012384 transportation and delivery Methods 0.000 description 15
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 14
• 125000003275 alpha amino acid group Chemical group 0.000 description 14
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 14
• 150000001412 amines Chemical class 0.000 description 14
• 108700021021 mRNA Vaccine Proteins 0.000 description 14
• 229940126582 mRNA vaccine Drugs 0.000 description 14
• WDSCDQQQRGGVPJ-AQABUGPSSA-N (e,2r,3r,8z)-8-[(8s,8as)-8-hydroxy-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-6-ylidene]-4,7-dimethyloct-4-ene-2,3-diol Chemical compound C[C@]1(O)CC(=C/C(C\C=C(/C)[C@@H](O)[C@@H](C)O)C)/CN2CCC[C@H]21 WDSCDQQQRGGVPJ-AQABUGPSSA-N 0.000 description 13
• 102220599672 Spindlin-1_D614G_mutation Human genes 0.000 description 13
• GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 13
• 102000005962 receptors Human genes 0.000 description 13
• 108020003175 receptors Proteins 0.000 description 13
• 238000013519 translation Methods 0.000 description 13
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 12
• 238000003776 cleavage reaction Methods 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 229940029575 guanosine Drugs 0.000 description 12
• WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 12
• AJAMRCUNWLZBDF-UHFFFAOYSA-N propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCCC AJAMRCUNWLZBDF-UHFFFAOYSA-N 0.000 description 12
• 238000000746 purification Methods 0.000 description 12
• 230000007017 scission Effects 0.000 description 12
• 241000700605 Viruses Species 0.000 description 11
• 125000003835 nucleoside group Chemical group 0.000 description 11
• 239000000126 substance Substances 0.000 description 11
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 10
• 108091007433 antigens Proteins 0.000 description 10
• 102000036639 antigens Human genes 0.000 description 10
• QPMJENKZJUFOON-PLNGDYQASA-N ethyl (z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate Chemical compound CCOC(=O)C(\C#N)=C(/Cl)C(F)(F)F QPMJENKZJUFOON-PLNGDYQASA-N 0.000 description 10
• 208000015181 infectious disease Diseases 0.000 description 10
• 238000006386 neutralization reaction Methods 0.000 description 10
• 150000003833 nucleoside derivatives Chemical class 0.000 description 10
• 102000004961 Furin Human genes 0.000 description 9
• 108090001126 Furin Proteins 0.000 description 9
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 9
• 201000010099 disease Diseases 0.000 description 9
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
• 238000004128 high performance liquid chromatography Methods 0.000 description 9
• 238000001727 in vivo Methods 0.000 description 9
• 230000002829 reductive effect Effects 0.000 description 9
• XBBMJUWOCGWHRP-UHFFFAOYSA-N 3-octanoyloxypropyl octanoate Chemical compound CCCCCCCC(=O)OCCCOC(=O)CCCCCCC XBBMJUWOCGWHRP-UHFFFAOYSA-N 0.000 description 8
• 241000282414 Homo sapiens Species 0.000 description 8
• 229910019142 PO4 Inorganic materials 0.000 description 8
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 8
• 235000021317 phosphate Nutrition 0.000 description 8
• 229920001223 polyethylene glycol Polymers 0.000 description 8
• 235000019260 propionic acid Nutrition 0.000 description 8
• 229940045145 uridine Drugs 0.000 description 8
• 238000002255 vaccination Methods 0.000 description 8
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical class NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 7
• 241001112090 Pseudovirus Species 0.000 description 7
• 239000004480 active ingredient Substances 0.000 description 7
• 238000007792 addition Methods 0.000 description 7
• 230000000890 antigenic effect Effects 0.000 description 7
• 229910052799 carbon Inorganic materials 0.000 description 7
• 229940104302 cytosine Drugs 0.000 description 7
• OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 7
• 230000014509 gene expression Effects 0.000 description 7
• 230000002209 hydrophobic effect Effects 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 125000005647 linker group Chemical group 0.000 description 7
• 239000012528 membrane Substances 0.000 description 7
• 239000000178 monomer Substances 0.000 description 7
• 239000010452 phosphate Substances 0.000 description 7
• 239000001294 propane Substances 0.000 description 7
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
• 229930024421 Adenine Natural products 0.000 description 6
• 241000711573 Coronaviridae Species 0.000 description 6
• SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 6
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 6
• ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
• 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 6
• 229960000643 adenine Drugs 0.000 description 6
• 239000002585 base Substances 0.000 description 6
• 230000008859 change Effects 0.000 description 6
• 238000006243 chemical reaction Methods 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 210000001808 exosome Anatomy 0.000 description 6
• 235000018977 lysine Nutrition 0.000 description 6
• 210000004379 membrane Anatomy 0.000 description 6
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 6
• 230000007935 neutral effect Effects 0.000 description 6
• 229910052757 nitrogen Inorganic materials 0.000 description 6
• 238000005457 optimization Methods 0.000 description 6
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
• 150000004713 phosphodiesters Chemical class 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 239000000047 product Substances 0.000 description 6
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 6
• 239000007787 solid Substances 0.000 description 6
• 238000013518 transcription Methods 0.000 description 6
• 230000035897 transcription Effects 0.000 description 6
• 239000004471 Glycine Substances 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 102000018697 Membrane Proteins Human genes 0.000 description 5
• 108010052285 Membrane Proteins Proteins 0.000 description 5
• 241000699670 Mus sp. Species 0.000 description 5
• 108091093037 Peptide nucleic acid Proteins 0.000 description 5
• 108010089430 Phosphoproteins Proteins 0.000 description 5
• 108010076039 Polyproteins Proteins 0.000 description 5
• 125000000217 alkyl group Chemical group 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 230000005540 biological transmission Effects 0.000 description 5
• 230000015556 catabolic process Effects 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 229960001231 choline Drugs 0.000 description 5
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 5
• 238000006731 degradation reaction Methods 0.000 description 5
• 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
• 238000001990 intravenous administration Methods 0.000 description 5
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
• 230000003278 mimic effect Effects 0.000 description 5
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 5
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 229920002477 rna polymer Polymers 0.000 description 5
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 5
• HXVVOLDXHIMZJZ-UHFFFAOYSA-N 3-[2-[2-[2-[bis[3-(dodecylamino)-3-oxopropyl]amino]ethyl-[3-(dodecylamino)-3-oxopropyl]amino]ethylamino]ethyl-[3-(dodecylamino)-3-oxopropyl]amino]-n-dodecylpropanamide Chemical compound CCCCCCCCCCCCNC(=O)CCN(CCC(=O)NCCCCCCCCCCCC)CCN(CCC(=O)NCCCCCCCCCCCC)CCNCCN(CCC(=O)NCCCCCCCCCCCC)CCC(=O)NCCCCCCCCCCCC HXVVOLDXHIMZJZ-UHFFFAOYSA-N 0.000 description 4
• PEHVGBZKEYRQSX-UHFFFAOYSA-N 7-deaza-adenine Chemical compound NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 4
• HCGHYQLFMPXSDU-UHFFFAOYSA-N 7-methyladenine Chemical compound C1=NC(N)=C2N(C)C=NC2=N1 HCGHYQLFMPXSDU-UHFFFAOYSA-N 0.000 description 4
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
• 239000004472 Lysine Substances 0.000 description 4
• 102000007982 Phosphoproteins Human genes 0.000 description 4
• 230000002378 acidificating effect Effects 0.000 description 4
• 239000013543 active substance Substances 0.000 description 4
• 229960005305 adenosine Drugs 0.000 description 4
• 230000002776 aggregation Effects 0.000 description 4
• 238000004220 aggregation Methods 0.000 description 4
• 235000003704 aspartic acid Nutrition 0.000 description 4
• HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 4
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 4
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
• 238000004422 calculation algorithm Methods 0.000 description 4
• 125000002091 cationic group Chemical group 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 230000034994 death Effects 0.000 description 4
• 231100000517 death Toxicity 0.000 description 4
• 125000000524 functional group Chemical group 0.000 description 4
• 210000003494 hepatocyte Anatomy 0.000 description 4
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
• 239000007791 liquid phase Substances 0.000 description 4
• 210000000066 myeloid cell Anatomy 0.000 description 4
• NFQBIAXADRDUGK-KWXKLSQISA-N n,n-dimethyl-2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/C\C=C/CCCCC NFQBIAXADRDUGK-KWXKLSQISA-N 0.000 description 4
• GLGLUQVVDHRLQK-WRBBJXAJSA-N n,n-dimethyl-2,3-bis[(z)-octadec-9-enoxy]propan-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/CCCCCCCC GLGLUQVVDHRLQK-WRBBJXAJSA-N 0.000 description 4
• 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 4
• 238000004007 reversed phase HPLC Methods 0.000 description 4
• 102200059763 rs28942096 Human genes 0.000 description 4
• 229960001153 serine Drugs 0.000 description 4
• 239000007790 solid phase Substances 0.000 description 4
• 241000894007 species Species 0.000 description 4
• 238000007920 subcutaneous administration Methods 0.000 description 4
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
• 230000032258 transport Effects 0.000 description 4
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 4
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
• 230000003612 virological effect Effects 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• UVBYMVOUBXYSFV-XUTVFYLZSA-N 1-methylpseudouridine Chemical compound O=C1NC(=O)N(C)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UVBYMVOUBXYSFV-XUTVFYLZSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 description 3
• 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
• 102000004127 Cytokines Human genes 0.000 description 3
• 108090000695 Cytokines Proteins 0.000 description 3
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
• 101710091045 Envelope protein Proteins 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
• 101000929928 Homo sapiens Angiotensin-converting enzyme 2 Proteins 0.000 description 3
• 102100034349 Integrase Human genes 0.000 description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 101710188315 Protein X Proteins 0.000 description 3
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• 108091028664 Ribonucleotide Proteins 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108020004459 Small interfering RNA Proteins 0.000 description 3
• 102220590604 Spindlin-1_K417N_mutation Human genes 0.000 description 3
• 239000007983 Tris buffer Substances 0.000 description 3
• NRLNQCOGCKAESA-KWXKLSQISA-N [(6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl] 4-(dimethylamino)butanoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC\C=C/C\C=C/CCCCC NRLNQCOGCKAESA-KWXKLSQISA-N 0.000 description 3
• 235000004279 alanine Nutrition 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 238000005571 anion exchange chromatography Methods 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• MVCRZALXJBDOKF-JPZHCBQBSA-N beta-hydroxywybutosine 5'-monophosphate Chemical compound C1=NC=2C(=O)N3C(CC(O)[C@H](NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O MVCRZALXJBDOKF-JPZHCBQBSA-N 0.000 description 3
• 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• 238000004364 calculation method Methods 0.000 description 3
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 229940088598 enzyme Drugs 0.000 description 3
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
• 235000013922 glutamic acid Nutrition 0.000 description 3
• 239000004220 glutamic acid Substances 0.000 description 3
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
• 235000004554 glutamine Nutrition 0.000 description 3
• 102000048657 human ACE2 Human genes 0.000 description 3
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 229960003786 inosine Drugs 0.000 description 3
• 229960000310 isoleucine Drugs 0.000 description 3
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 102000028499 poly(A) binding Human genes 0.000 description 3
• 108091023021 poly(A) binding Proteins 0.000 description 3
• 230000004481 post-translational protein modification Effects 0.000 description 3
• FOWDZVNRQHPXDO-UHFFFAOYSA-M propyl carbonate Chemical compound CCCOC([O-])=O FOWDZVNRQHPXDO-UHFFFAOYSA-M 0.000 description 3
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• HTUIWRWYYVBCFT-UHFFFAOYSA-N propyl hexanoate Chemical compound CCCCCC(=O)OCCC HTUIWRWYYVBCFT-UHFFFAOYSA-N 0.000 description 3
• 239000002336 ribonucleotide Substances 0.000 description 3
• 125000002652 ribonucleotide group Chemical group 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 239000004055 small Interfering RNA Substances 0.000 description 3
• HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 3
• 125000006850 spacer group Chemical group 0.000 description 3
• 229910052717 sulfur Inorganic materials 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• 239000001226 triphosphate Substances 0.000 description 3
• 238000000108 ultra-filtration Methods 0.000 description 3
• 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• YIMATHOGWXZHFX-WCTZXXKLSA-N (2r,3r,4r,5r)-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolane-2,4-diol Chemical compound COCCO[C@H]1[C@H](O)O[C@H](CO)[C@H]1O YIMATHOGWXZHFX-WCTZXXKLSA-N 0.000 description 2
• KYJLJOJCMUFWDY-UUOKFMHZSA-N (2r,3r,4s,5r)-2-(6-amino-8-azidopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound [N-]=[N+]=NC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O KYJLJOJCMUFWDY-UUOKFMHZSA-N 0.000 description 2
• OPCHFPHZPIURNA-MFERNQICSA-N (2s)-2,5-bis(3-aminopropylamino)-n-[2-(dioctadecylamino)acetyl]pentanamide Chemical compound CCCCCCCCCCCCCCCCCCN(CC(=O)NC(=O)[C@H](CCCNCCCN)NCCCN)CCCCCCCCCCCCCCCCCC OPCHFPHZPIURNA-MFERNQICSA-N 0.000 description 2
• WKJDWDLHIOUPPL-JSOSNVBQSA-N (2s)-2-amino-3-({[(2r)-2,3-bis(tetradecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCC WKJDWDLHIOUPPL-JSOSNVBQSA-N 0.000 description 2
• SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 2
• PLKOSISDOAHHCI-QYCRHRGJSA-N 1-[2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propyl]-4-methylpiperazine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCC(OCCCCCCCC\C=C/C\C=C/CCCCC)CN1CCN(C)CC1 PLKOSISDOAHHCI-QYCRHRGJSA-N 0.000 description 2
• UVBYMVOUBXYSFV-UHFFFAOYSA-N 1-methylpseudouridine Natural products O=C1NC(=O)N(C)C=C1C1C(O)C(O)C(CO)O1 UVBYMVOUBXYSFV-UHFFFAOYSA-N 0.000 description 2
• QUKPALAWEPMWOS-UHFFFAOYSA-N 1h-pyrazolo[3,4-d]pyrimidine Chemical class C1=NC=C2C=NNC2=N1 QUKPALAWEPMWOS-UHFFFAOYSA-N 0.000 description 2
• 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
• QJWLXRCSILVSPL-CLFAGFIQSA-N 2-[bis[(z)-octadec-9-enyl]amino]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCN(CCO)CCCCCCCC\C=C/CCCCCCCC QJWLXRCSILVSPL-CLFAGFIQSA-N 0.000 description 2
• JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 2
• FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
• VZQXUWKZDSEQRR-SDBHATRESA-N 2-methylthio-N(6)-(Delta(2)-isopentenyl)adenosine Chemical compound C12=NC(SC)=NC(NCC=C(C)C)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VZQXUWKZDSEQRR-SDBHATRESA-N 0.000 description 2
• GJTBSTBJLVYKAU-XVFCMESISA-N 2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C=C1 GJTBSTBJLVYKAU-XVFCMESISA-N 0.000 description 2
• BINGDNLMMYSZFR-QYVSTXNMSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,7-dimethyl-5h-imidazo[1,2-a]purin-9-one Chemical compound C1=NC=2C(=O)N3C(C)=C(C)N=C3NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O BINGDNLMMYSZFR-QYVSTXNMSA-N 0.000 description 2
• OFNURJYUSVVJPM-UHFFFAOYSA-N 3-octylundecanoic acid Chemical compound CCCCCCCCC(CC(O)=O)CCCCCCCC OFNURJYUSVVJPM-UHFFFAOYSA-N 0.000 description 2
• RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
• UFQDKRWQSFLPQY-UHFFFAOYSA-N 4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound Cl.C1CN=CN1 UFQDKRWQSFLPQY-UHFFFAOYSA-N 0.000 description 2
• QUZQVVNSDQCAOL-WOUKDFQISA-N 4-demethylwyosine Chemical compound N1C(C)=CN(C(C=2N=C3)=O)C1=NC=2N3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QUZQVVNSDQCAOL-WOUKDFQISA-N 0.000 description 2
• OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 2
• VSCNRXVDHRNJOA-PNHWDRBUSA-N 5-(carboxymethylaminomethyl)uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CNCC(O)=O)=C1 VSCNRXVDHRNJOA-PNHWDRBUSA-N 0.000 description 2
• RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-(hydroxymethyl)cytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 description 2
• QXDXBKZJFLRLCM-UAKXSSHOSA-N 5-hydroxyuridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(O)=C1 QXDXBKZJFLRLCM-UAKXSSHOSA-N 0.000 description 2
• YIZYCHKPHCPKHZ-PNHWDRBUSA-N 5-methoxycarbonylmethyluridine Chemical compound O=C1NC(=O)C(CC(=O)OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YIZYCHKPHCPKHZ-PNHWDRBUSA-N 0.000 description 2
• LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical class CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
• HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 2
• MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• 102220621765 AP-3 complex subunit beta-1_Q57H_mutation Human genes 0.000 description 2
• 108020005176 AU Rich Elements Proteins 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000271566 Aves Species 0.000 description 2
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
• LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
• FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 2
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
• 108010017826 DNA Polymerase I Proteins 0.000 description 2
• 102000004594 DNA Polymerase I Human genes 0.000 description 2
• 108010016626 Dipeptides Proteins 0.000 description 2
• 206010013975 Dyspnoeas Diseases 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 239000005977 Ethylene Substances 0.000 description 2
• 108060002716 Exonuclease Proteins 0.000 description 2
• 101800001768 Exoribonuclease Proteins 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 108091093094 Glycol nucleic acid Proteins 0.000 description 2
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
• 229930010555 Inosine Natural products 0.000 description 2
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
• 102000004388 Interleukin-4 Human genes 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• ZKZBPNGNEQAJSX-REOHCLBHSA-N L-selenocysteine Chemical compound [SeH]C[C@H](N)C(O)=O ZKZBPNGNEQAJSX-REOHCLBHSA-N 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
• 239000000232 Lipid Bilayer Substances 0.000 description 2
• ZBYRSRLCXTUFLJ-IOSLPCCCSA-O N(2),N(7)-dimethylguanosine Chemical compound CNC=1NC(C=2[N+](=CN([C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)C=2N=1)C)=O ZBYRSRLCXTUFLJ-IOSLPCCCSA-O 0.000 description 2
• VQAYFKKCNSOZKM-IOSLPCCCSA-N N(6)-methyladenosine Chemical compound C1=NC=2C(NC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VQAYFKKCNSOZKM-IOSLPCCCSA-N 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 101710087110 ORF6 protein Proteins 0.000 description 2
• 101710128341 ORF7a protein Proteins 0.000 description 2
• 101710125107 ORF7b protein Proteins 0.000 description 2
• 101710096370 ORF8 protein Proteins 0.000 description 2
• REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 229920002873 Polyethylenimine Polymers 0.000 description 2
• 108091000106 RNA cap binding Proteins 0.000 description 2
• 102000028391 RNA cap binding Human genes 0.000 description 2
• 230000009948 RNA mutation Effects 0.000 description 2
• 108091005774 SARS-CoV-2 proteins Proteins 0.000 description 2
• 238000012300 Sequence Analysis Methods 0.000 description 2
• 101000953880 Severe acute respiratory syndrome coronavirus 2 Membrane protein Proteins 0.000 description 2
• 101000779242 Severe acute respiratory syndrome coronavirus 2 ORF3a protein Proteins 0.000 description 2
• 102220590546 Spindlin-1_N440K_mutation Human genes 0.000 description 2
• 102220599614 Spindlin-1_Q677H_mutation Human genes 0.000 description 2
• 102220590680 Spindlin-1_S13I_mutation Human genes 0.000 description 2
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 101710135104 Uncharacterized protein p6 Proteins 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 102220506811 Vitelline membrane outer layer protein 1 homolog_I82T_mutation Human genes 0.000 description 2
• YXNIEZJFCGTDKV-UHFFFAOYSA-N X-Nucleosid Natural products O=C1N(CCC(N)C(O)=O)C(=O)C=CN1C1C(O)C(O)C(CO)O1 YXNIEZJFCGTDKV-UHFFFAOYSA-N 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 238000001261 affinity purification Methods 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 2
• 229940077484 ammonium bromide Drugs 0.000 description 2
• 125000000129 anionic group Chemical group 0.000 description 2
• 125000004104 aryloxy group Chemical group 0.000 description 2
• 235000009582 asparagine Nutrition 0.000 description 2
• 229960001230 asparagine Drugs 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• SVGGKWILBMPIJV-UHFFFAOYSA-N butyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCCCC SVGGKWILBMPIJV-UHFFFAOYSA-N 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• 102220429344 c.456G>T Human genes 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 238000005251 capillar electrophoresis Methods 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 238000004590 computer program Methods 0.000 description 2
• 239000000356 contaminant Substances 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 2
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 229960000684 cytarabine Drugs 0.000 description 2
• 238000000432 density-gradient centrifugation Methods 0.000 description 2
• PIZLBWGMERQCOC-UHFFFAOYSA-N dibenzyl carbonate Chemical compound C=1C=CC=CC=1COC(=O)OCC1=CC=CC=C1 PIZLBWGMERQCOC-UHFFFAOYSA-N 0.000 description 2
• 238000001085 differential centrifugation Methods 0.000 description 2
• ZPTBLXKRQACLCR-XVFCMESISA-N dihydrouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)CC1 ZPTBLXKRQACLCR-XVFCMESISA-N 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 2
• MWRBNPKJOOWZPW-CLFAGFIQSA-N dioleoyl phosphatidylethanolamine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-CLFAGFIQSA-N 0.000 description 2
• 239000006185 dispersion Substances 0.000 description 2
• 239000002612 dispersion medium Substances 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 238000013504 emergency use authorization Methods 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 230000012202 endocytosis Effects 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 238000006911 enzymatic reaction Methods 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• 102000013165 exonuclease Human genes 0.000 description 2
• 210000003608 fece Anatomy 0.000 description 2
• 238000001914 filtration Methods 0.000 description 2
• 238000000684 flow cytometry Methods 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 238000007306 functionalization reaction Methods 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 2
• 125000001475 halogen functional group Chemical group 0.000 description 2
• 125000005843 halogen group Chemical group 0.000 description 2
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 239000003547 immunosorbent Substances 0.000 description 2
• 230000000415 inactivating effect Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 238000000185 intracerebroventricular administration Methods 0.000 description 2
• 238000007913 intrathecal administration Methods 0.000 description 2
• 239000007951 isotonicity adjuster Substances 0.000 description 2
• 239000010410 layer Substances 0.000 description 2
• 239000002479 lipoplex Substances 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 150000002669 lysines Chemical class 0.000 description 2
• 230000000873 masking effect Effects 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 230000034217 membrane fusion Effects 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 238000007069 methylation reaction Methods 0.000 description 2
• 239000000693 micelle Substances 0.000 description 2
• RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
• 238000010172 mouse model Methods 0.000 description 2
• 229940031348 multivalent vaccine Drugs 0.000 description 2
• 210000000663 muscle cell Anatomy 0.000 description 2
• KHGRPHJXYWLEFQ-HKTUAWPASA-N n,n-dimethyl-2,3-bis[(9z,12z,15z)-octadeca-9,12,15-trienoxy]propan-1-amine Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/C\C=C/C\C=C/CC KHGRPHJXYWLEFQ-HKTUAWPASA-N 0.000 description 2
• 229940078490 n,n-dimethylglycine Drugs 0.000 description 2
• GOLAKLHPPDDLST-UHFFFAOYSA-N octadeca-9,12-dien-1-amine Chemical compound CCCCCC=CCC=CCCCCCCCCN GOLAKLHPPDDLST-UHFFFAOYSA-N 0.000 description 2
• 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 2
• 229940049964 oleate Drugs 0.000 description 2
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
• 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• SECPZKHBENQXJG-FPLPWBNLSA-M palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC([O-])=O SECPZKHBENQXJG-FPLPWBNLSA-M 0.000 description 2
• 230000006320 pegylation Effects 0.000 description 2
• 150000002972 pentoses Chemical class 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 150000008298 phosphoramidates Chemical class 0.000 description 2
• 150000003013 phosphoric acid derivatives Chemical group 0.000 description 2
• 210000002381 plasma Anatomy 0.000 description 2
• 239000013612 plasmid Substances 0.000 description 2
• 210000004909 pre-ejaculatory fluid Anatomy 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 108020001580 protein domains Proteins 0.000 description 2
• 229940096913 pseudoisocytidine Drugs 0.000 description 2
• 238000000275 quality assurance Methods 0.000 description 2
• 238000003908 quality control method Methods 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 239000002342 ribonucleoside Substances 0.000 description 2
• 102220223340 rs1060502592 Human genes 0.000 description 2
• 102220277043 rs1553408229 Human genes 0.000 description 2
• 102220075059 rs529697285 Human genes 0.000 description 2
• 102220046173 rs587782706 Human genes 0.000 description 2
• RHFUOMFWUGWKKO-UHFFFAOYSA-N s2C Natural products S=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 RHFUOMFWUGWKKO-UHFFFAOYSA-N 0.000 description 2
• 229940055619 selenocysteine Drugs 0.000 description 2
• ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 2
• 235000016491 selenocysteine Nutrition 0.000 description 2
• 238000001542 size-exclusion chromatography Methods 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 125000000547 substituted alkyl group Chemical group 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 239000011593 sulfur Substances 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 230000008719 thickening Effects 0.000 description 2
• 239000002562 thickening agent Substances 0.000 description 2
• 229940113082 thymine Drugs 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 230000014621 translational initiation Effects 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• 108010027510 vaccinia virus capping enzyme Proteins 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 229960003636 vidarabine Drugs 0.000 description 2
• 210000002845 virion Anatomy 0.000 description 2
• 230000008673 vomiting Effects 0.000 description 2
• KZIQWSQXCKPZBG-KWXKLSQISA-N (11Z,14Z)-2-(dimethylamino)-2-[(9Z,12Z)-octadeca-9,12-dienyl]icosa-11,14-dien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(CO)(CCCCCCCC\C=C/C\C=C/CCCCC)N(C)C KZIQWSQXCKPZBG-KWXKLSQISA-N 0.000 description 1
• DFLGHUGIWAYXFV-XVTLYKPTSA-N (12z,15z)-n,n-dimethylhenicosa-12,15-dien-4-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(N(C)C)CCC DFLGHUGIWAYXFV-XVTLYKPTSA-N 0.000 description 1
• VKRSOPFWJRDTME-HDXUUTQWSA-N (13z,16z)-n,n-dimethyldocosa-13,16-dien-5-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(N(C)C)CCCC VKRSOPFWJRDTME-HDXUUTQWSA-N 0.000 description 1
• BZZLBAMHZHKRFK-XVTLYKPTSA-N (14z,17z)-n,n-dimethyltricosa-14,17-dien-4-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(N(C)C)CCC BZZLBAMHZHKRFK-XVTLYKPTSA-N 0.000 description 1
• MRGAZQLDRACERW-HDXUUTQWSA-N (14z,17z)-n,n-dimethyltricosa-14,17-dien-6-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(N(C)C)CCCCC MRGAZQLDRACERW-HDXUUTQWSA-N 0.000 description 1
• BZRXZULJYFAROV-HDXUUTQWSA-N (15z,18z)-n,n-dimethyltetracosa-15,18-dien-5-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(N(C)C)CCCC BZRXZULJYFAROV-HDXUUTQWSA-N 0.000 description 1
• NYRYVZIUPOHALZ-QGLGPCELSA-N (15z,18z)-n,n-dimethyltetracosa-15,18-dien-7-amine Chemical compound CCCCCCC(N(C)C)CCCCCCC\C=C/C\C=C/CCCCC NYRYVZIUPOHALZ-QGLGPCELSA-N 0.000 description 1
• DELUIQJQMCTOCD-HDXUUTQWSA-N (16z,19z)-n,n-dimethylpentacosa-16,19-dien-6-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(N(C)C)CCCCC DELUIQJQMCTOCD-HDXUUTQWSA-N 0.000 description 1
• DGQYVBDAVMYDJC-QGLGPCELSA-N (17z,20z)-n,n-dimethylhexacosa-17,20-dien-7-amine Chemical compound CCCCCCC(N(C)C)CCCCCCCCC\C=C/C\C=C/CCCCC DGQYVBDAVMYDJC-QGLGPCELSA-N 0.000 description 1
• ZFQNFOUTWXVNBG-QGLGPCELSA-N (19z,22z)-n,n-dimethyloctacosa-19,22-dien-7-amine Chemical compound CCCCCCC(N(C)C)CCCCCCCCCCC\C=C/C\C=C/CCCCC ZFQNFOUTWXVNBG-QGLGPCELSA-N 0.000 description 1
• POBBAOCNGBEZJQ-AUGURXLVSA-N (20z,23z)-n,n-dimethylnonacosa-20,23-dien-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCC\C=C/C\C=C/CCCCC POBBAOCNGBEZJQ-AUGURXLVSA-N 0.000 description 1
• IHKVCZISZBWDEJ-NFYLBXPESA-N (20z,23z)-n-ethyl-n-methylnonacosa-20,23-dien-10-amine Chemical compound CCCCCCCCCC(N(C)CC)CCCCCCCCC\C=C/C\C=C/CCCCC IHKVCZISZBWDEJ-NFYLBXPESA-N 0.000 description 1
• GRQMMQSAFMPMNM-AUGURXLVSA-N (21z,24z)-n,n-dimethyltriaconta-21,24-dien-9-amine Chemical compound CCCCCCCCC(N(C)C)CCCCCCCCCCC\C=C/C\C=C/CCCCC GRQMMQSAFMPMNM-AUGURXLVSA-N 0.000 description 1
• FVHCEZRYPCZLAX-AUGURXLVSA-N (22z,25z)-n,n-dimethylhentriaconta-22,25-dien-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCCC\C=C/C\C=C/CCCCC FVHCEZRYPCZLAX-AUGURXLVSA-N 0.000 description 1
• YZSZLBRBVWAXFW-LNYQSQCFSA-N (2R,3R,4S,5R)-2-(2-amino-6-hydroxy-6-methoxy-3H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1(O)NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YZSZLBRBVWAXFW-LNYQSQCFSA-N 0.000 description 1
• JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
• UUDVSZSQPFXQQM-GIWSHQQXSA-N (2r,3s,4r,5r)-2-(6-aminopurin-9-yl)-3-fluoro-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@]1(O)F UUDVSZSQPFXQQM-GIWSHQQXSA-N 0.000 description 1
• RAUUWSIWMBUIDV-VTMHRMHWSA-N (2s)-1-[(13z,16z)-docosa-13,16-dienoxy]-3-hexoxy-n,n-dimethylpropan-2-amine Chemical compound CCCCCCOC[C@H](N(C)C)COCCCCCCCCCCCC\C=C/C\C=C/CCCCC RAUUWSIWMBUIDV-VTMHRMHWSA-N 0.000 description 1
• GFQUOOFKQHZXHF-WZCSSZMCSA-N (2s)-1-[(z)-docos-13-enoxy]-3-hexoxy-n,n-dimethylpropan-2-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC[C@@H](N(C)C)COCCCCCC GFQUOOFKQHZXHF-WZCSSZMCSA-N 0.000 description 1
• XUTPKVMBJILQJR-YSLTZPBHSA-N (2s)-1-hexoxy-3-[(11z,14z)-icosa-11,14-dienoxy]-n,n-dimethylpropan-2-amine Chemical compound CCCCCCOC[C@H](N(C)C)COCCCCCCCCCC\C=C/C\C=C/CCCCC XUTPKVMBJILQJR-YSLTZPBHSA-N 0.000 description 1
• UHWVIVRBTWBYQX-XZIBJWJKSA-N (2s)-2-amino-3-hydroxy-n,n-bis[2-[(z)-octadec-9-enoxy]ethyl]propanamide Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCN(C(=O)[C@@H](N)CO)CCOCCCCCCCC\C=C/CCCCCCCC UHWVIVRBTWBYQX-XZIBJWJKSA-N 0.000 description 1
• MYUOTPIQBPUQQU-CKTDUXNWSA-N (2s,3r)-2-amino-n-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-methylsulfanylpurin-6-yl]carbamoyl]-3-hydroxybutanamide Chemical compound C12=NC(SC)=NC(NC(=O)NC(=O)[C@@H](N)[C@@H](C)O)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O MYUOTPIQBPUQQU-CKTDUXNWSA-N 0.000 description 1
• GPTUGCGYEMEAOC-IBZYUGMLSA-N (2s,3r)-2-amino-n-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-methylcarbamoyl]-3-hydroxybutanamide Chemical compound C1=NC=2C(N(C)C(=O)NC(=O)[C@@H](N)[C@H](O)C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O GPTUGCGYEMEAOC-IBZYUGMLSA-N 0.000 description 1
• VBIFKRSXZKIWFS-UNGPWUORSA-N (9R)-9-[2-[3-[(dimethylamino)methyl]-5-[(3R)-3,4-di(octanoyloxy)butoxy]phenoxy]ethyl]octadecanedioic acid Chemical compound CCCCCCCC(=O)OC[C@@H](CCOC1=CC(=CC(=C1)OCC[C@H](CCCCCCCCC(=O)O)CCCCCCCC(=O)O)CN(C)C)OC(=O)CCCCCCC VBIFKRSXZKIWFS-UNGPWUORSA-N 0.000 description 1
• VBIFKRSXZKIWFS-VROXBXNJSA-N (9R)-9-[2-[3-[(dimethylamino)methyl]-5-[(3S)-3,4-di(octanoyloxy)butoxy]phenoxy]ethyl]octadecanedioic acid Chemical compound CCCCCCCC(=O)OC[C@H](CCOC1=CC(=CC(=C1)OCC[C@H](CCCCCCCCC(=O)O)CCCCCCCC(=O)O)CN(C)C)OC(=O)CCCCCCC VBIFKRSXZKIWFS-VROXBXNJSA-N 0.000 description 1
• PSNWQONWUAUNTD-XIMJPLDWSA-N (9Z,12Z)-19-[3-[(7Z,10Z)-18-carboxyoctadeca-7,10-dienyl]-5-[(dimethylamino)methyl]phenyl]nonadeca-9,12-dienoic acid Chemical compound CN(C)CC1=CC(=CC(=C1)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O PSNWQONWUAUNTD-XIMJPLDWSA-N 0.000 description 1
• FQCRMICWSSEGOL-OIRSPXBMSA-N (9Z,12Z)-19-[3-[(7Z,10Z)-18-carboxyoctadeca-7,10-dienyl]-5-[3-(diethylamino)propoxycarbonyloxymethyl]phenyl]nonadeca-9,12-dienoic acid Chemical compound CCN(CC)CCCOC(=O)OCC1=CC(=CC(=C1)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O FQCRMICWSSEGOL-OIRSPXBMSA-N 0.000 description 1
• 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
• YBCJEYSRAQIVIR-MERKUPPJSA-N (9Z,12Z,27Z,30Z)-20-(4-piperidin-1-ylbutanoyloxymethyl)nonatriaconta-9,12,27,30-tetraenedioic acid Chemical compound C1CCN(CC1)CCCC(=O)OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O YBCJEYSRAQIVIR-MERKUPPJSA-N 0.000 description 1
• VWDUJAKMNCPUEL-XIMJPLDWSA-N (9Z,12Z,27Z,30Z)-20-[(1,3-dimethylpyrrolidine-3-carbonyl)oxymethyl]nonatriaconta-9,12,27,30-tetraenedioic acid Chemical compound CC1(CN(C)CC1)C(OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)=O VWDUJAKMNCPUEL-XIMJPLDWSA-N 0.000 description 1
• UTQWRDGZSYSHEN-XIMJPLDWSA-N (9Z,12Z,27Z,30Z)-20-[4-(dimethylamino)butanoyloxymethyl]nonatriaconta-9,12,27,30-tetraenedioic acid Chemical compound CN(CCCC(=O)OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)CCCCCC/C=C\C/C=C\CCCCCCCC(=O)O)C UTQWRDGZSYSHEN-XIMJPLDWSA-N 0.000 description 1
• LAUDGJVOMSXMRM-MCOFMCJXSA-N (9Z,30Z)-20-[4-[3-(dimethylamino)propoxycarbonyloxy]hexadecanoyloxy]nonatriaconta-9,30-dienedioic acid Chemical compound CCCCCCCCCCCCC(OC(=O)OCCCN(C)C)CCC(=O)OC(CCCCCCCCC/C=C\CCCCCCCC(=O)O)CCCCCCCCC/C=C\CCCCCCCC(=O)O LAUDGJVOMSXMRM-MCOFMCJXSA-N 0.000 description 1
• 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
• 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• MISZWZHGSSSVEE-MSUUIHNZSA-N (z)-n,n-dimethylhentriacont-22-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCCC\C=C/CCCCCCCC MISZWZHGSSSVEE-MSUUIHNZSA-N 0.000 description 1
• SDJYFFRZEJMSHR-MSUUIHNZSA-N (z)-n,n-dimethylheptacos-18-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCC\C=C/CCCCCCCC SDJYFFRZEJMSHR-MSUUIHNZSA-N 0.000 description 1
• DMKFBCRXSPDHGN-PFONDFGASA-N (z)-n,n-dimethylheptacos-20-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCC\C=C/CCCCCC DMKFBCRXSPDHGN-PFONDFGASA-N 0.000 description 1
• YULDRMDDVGOLRP-MSUUIHNZSA-N (z)-n,n-dimethylhexacos-17-en-9-amine Chemical compound CCCCCCCC\C=C/CCCCCCCC(N(C)C)CCCCCCCC YULDRMDDVGOLRP-MSUUIHNZSA-N 0.000 description 1
• VAEPXOIOCOVXOD-GYHWCHFESA-N (z)-n,n-dimethylnonacos-14-en-10-amine Chemical compound CCCCCCCCCCCCCC\C=C/CCCC(N(C)C)CCCCCCCCC VAEPXOIOCOVXOD-GYHWCHFESA-N 0.000 description 1
• GOSOKZSRSXUCAH-VXPUYCOJSA-N (z)-n,n-dimethylnonacos-17-en-10-amine Chemical compound CCCCCCCCCCC\C=C/CCCCCCC(N(C)C)CCCCCCCCC GOSOKZSRSXUCAH-VXPUYCOJSA-N 0.000 description 1
• LHULGZVVKZHNIJ-MSUUIHNZSA-N (z)-n,n-dimethylnonacos-20-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCC\C=C/CCCCCCCC LHULGZVVKZHNIJ-MSUUIHNZSA-N 0.000 description 1
• PKPFJIXXVGJSKM-NXVVXOECSA-N (z)-n,n-dimethylpentacos-16-en-8-amine Chemical compound CCCCCCCC\C=C/CCCCCCCC(N(C)C)CCCCCCC PKPFJIXXVGJSKM-NXVVXOECSA-N 0.000 description 1
• PPDDFVKQPSPFAB-MSUUIHNZSA-N (z)-n,n-dimethyltritriacont-24-en-10-amine Chemical compound CCCCCCCCCC(N(C)C)CCCCCCCCCCCCC\C=C/CCCCCCCC PPDDFVKQPSPFAB-MSUUIHNZSA-N 0.000 description 1
• FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical compound C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
• KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
• JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 description 1
• LAYACISSSJRSMU-KLMICZSBSA-N 1-(6,6-dioctoxyhexanoyloxy)pentadecan-3-yl (2R)-pyrrolidine-2-carboxylate Chemical compound N1[C@H](CCC1)C(=O)OC(CCOC(CCCCC(OCCCCCCCC)OCCCCCCCC)=O)CCCCCCCCCCCC LAYACISSSJRSMU-KLMICZSBSA-N 0.000 description 1
• OYTVCAGSWWRUII-DWJKKKFUSA-N 1-Methyl-1-deazapseudouridine Chemical compound CC1C=C(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O OYTVCAGSWWRUII-DWJKKKFUSA-N 0.000 description 1
• MIXBUOXRHTZHKR-XUTVFYLZSA-N 1-Methylpseudoisocytidine Chemical compound CN1C=C(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O MIXBUOXRHTZHKR-XUTVFYLZSA-N 0.000 description 1
• KRNRCQZJTZWJBO-AUGURXLVSA-N 1-[(13z,16z)-docosa-13,16-dienoxy]-n,n-dimethyl-3-octoxypropan-2-amine Chemical compound CCCCCCCCOCC(N(C)C)COCCCCCCCCCCCC\C=C/C\C=C/CCCCC KRNRCQZJTZWJBO-AUGURXLVSA-N 0.000 description 1
• CIGFGRPIZLSWJD-HDXUUTQWSA-N 1-[(20z,23z)-nonacosa-20,23-dien-10-yl]pyrrolidine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(CCCCCCCCC)N1CCCC1 CIGFGRPIZLSWJD-HDXUUTQWSA-N 0.000 description 1
• VGHXKGWSRNEDEP-OJKLQORTSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidine-5-carboxylic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)N1C(=O)NC(=O)C(C(O)=O)=C1 VGHXKGWSRNEDEP-OJKLQORTSA-N 0.000 description 1
• KYEKLQMDNZPEFU-KVTDHHQDSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)N=C1 KYEKLQMDNZPEFU-KVTDHHQDSA-N 0.000 description 1
• UTQUILVPBZEHTK-ZOQUXTDFSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UTQUILVPBZEHTK-ZOQUXTDFSA-N 0.000 description 1
• HXVKEKIORVUWDR-FDDDBJFASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(methylaminomethyl)-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(CNC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HXVKEKIORVUWDR-FDDDBJFASA-N 0.000 description 1
• KJLRIEFCMSGNSI-HKUMRIAESA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(3-methylbut-3-enylamino)methyl]-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(CNCCC(=C)C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 KJLRIEFCMSGNSI-HKUMRIAESA-N 0.000 description 1
• HLBIEOQUEHEDCR-HKUMRIAESA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(3-methylbut-3-enylamino)methyl]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(CNCCC(=C)C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HLBIEOQUEHEDCR-HKUMRIAESA-N 0.000 description 1
• RKSLVDIXBGWPIS-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 RKSLVDIXBGWPIS-UAKXSSHOSA-N 0.000 description 1
• BTFXIEGOSDSOGN-KWCDMSRLSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione Chemical compound O=C1NC(=O)C(C)CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 BTFXIEGOSDSOGN-KWCDMSRLSA-N 0.000 description 1
• QLOCVMVCRJOTTM-TURQNECASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 QLOCVMVCRJOTTM-TURQNECASA-N 0.000 description 1
• QPHRQMAYYMYWFW-FJGDRVTGSA-N 1-[(2r,3s,4r,5r)-3-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 QPHRQMAYYMYWFW-FJGDRVTGSA-N 0.000 description 1
• SFJARXCDXKWUDD-MAZCIEHSSA-N 1-[3-amino-2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propyl]piperidin-4-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOC(N)C(OCCCCCCCC\C=C/C\C=C/CCCCC)CN1CCC(O)CC1 SFJARXCDXKWUDD-MAZCIEHSSA-N 0.000 description 1
• QETFUWLJQVVPJW-UHFFFAOYSA-N 1-[4-[2-[2-(didodecylamino)ethyl-dodecylamino]acetyl]piperazin-1-yl]-2-[di(nonyl)amino]ethanone Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CC(=O)N1CCN(CC1)C(=O)CN(CCCCCCCCC)CCCCCCCCC QETFUWLJQVVPJW-UHFFFAOYSA-N 0.000 description 1
• FVFLIHLOWLUEPP-UHFFFAOYSA-N 1-[4-[2-[2-(didodecylamino)ethyl-nonylamino]acetyl]piperazin-1-yl]-2-[di(nonyl)amino]ethanone Chemical compound C(CCCCCCCCCCC)N(CCN(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCC)CCCCCCCCC)=O)CCCCCCCCC)CCCCCCCCCCCC FVFLIHLOWLUEPP-UHFFFAOYSA-N 0.000 description 1
• QZQDTRSJACDICN-UHFFFAOYSA-N 1-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-[di(tetradecyl)amino]ethanone Chemical compound C(CCCCCCCC)N(CCN(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCCCCCCC)CCCCCCCCCCCCCC)=O)CCCCCCCCC)CCCCCCCCC QZQDTRSJACDICN-UHFFFAOYSA-N 0.000 description 1
• GUNOEKASBVILNS-UHFFFAOYSA-N 1-methyl-1-deaza-pseudoisocytidine Chemical compound CC(C=C1C(C2O)OC(CO)C2O)=C(N)NC1=O GUNOEKASBVILNS-UHFFFAOYSA-N 0.000 description 1
• VCAPOSNTDGEWSI-QYCRHRGJSA-N 1-methyl-3,3-bis[(9Z,12Z)-octadeca-9,12-dienyl]azetidine Chemical compound CN1CC(C1)(CCCCCCCC\C=C/C\C=C/CCCCC)CCCCCCCC\C=C/C\C=C/CCCCC VCAPOSNTDGEWSI-QYCRHRGJSA-N 0.000 description 1
• GFYLSDSUCHVORB-IOSLPCCCSA-N 1-methyladenosine Chemical compound C1=NC=2C(=N)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O GFYLSDSUCHVORB-IOSLPCCCSA-N 0.000 description 1
• UTAIYTHAJQNQDW-KQYNXXCUSA-N 1-methylguanosine Chemical compound C1=NC=2C(=O)N(C)C(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UTAIYTHAJQNQDW-KQYNXXCUSA-N 0.000 description 1
• WJNGQIYEQLPJMN-IOSLPCCCSA-N 1-methylinosine Chemical compound C1=NC=2C(=O)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WJNGQIYEQLPJMN-IOSLPCCCSA-N 0.000 description 1
• 125000004486 1-methylpiperidin-3-yl group Chemical group CN1CC(CCC1)* 0.000 description 1
• RUYTUSMGGNWWNM-UHFFFAOYSA-N 14-[3-(13-carboxytridecyl)-5-[(dimethylamino)methyl]phenyl]tetradecanoic acid Chemical compound CN(C)Cc1cc(CCCCCCCCCCCCCC(O)=O)cc(CCCCCCCCCCCCCC(O)=O)c1 RUYTUSMGGNWWNM-UHFFFAOYSA-N 0.000 description 1
• BNGVWAFGHGJATM-UHFFFAOYSA-N 1h-imidazo[1,5-a][1,3,5]triazin-2-one Chemical class N1C(=O)N=CN2C=NC=C21 BNGVWAFGHGJATM-UHFFFAOYSA-N 0.000 description 1
• UHUHBFMZVCOEOV-UHFFFAOYSA-N 1h-imidazo[4,5-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1N=CN2 UHUHBFMZVCOEOV-UHFFFAOYSA-N 0.000 description 1
• HUTNOYOBQPAKIA-UHFFFAOYSA-N 1h-pyrazin-2-one Chemical class OC1=CN=CC=N1 HUTNOYOBQPAKIA-UHFFFAOYSA-N 0.000 description 1
• 101800001779 2'-O-methyltransferase Proteins 0.000 description 1
• 101800003073 2'-O-methyltransferase nsp16 Proteins 0.000 description 1
• QISHSLOVZOLLQT-MAZCIEHSSA-N 2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCC(CO)OCCCCCCCC\C=C/C\C=C/CCCCC QISHSLOVZOLLQT-MAZCIEHSSA-N 0.000 description 1
• LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 1
• KWVJHCQQUFDPLU-YEUCEMRASA-N 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KWVJHCQQUFDPLU-YEUCEMRASA-N 0.000 description 1
• WALUVDCNGPQPOD-UHFFFAOYSA-M 2,3-di(tetradecoxy)propyl-(2-hydroxyethyl)-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCOCC(C[N+](C)(C)CCO)OCCCCCCCCCCCCCC WALUVDCNGPQPOD-UHFFFAOYSA-M 0.000 description 1
• PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical compound NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
• MXIUVORMADYMHK-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-(didodecylamino)ethyl-dodecylamino]acetyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCCCCC)N(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CCCCCCCCCCCC)=O)CCCCCCCCCCCC MXIUVORMADYMHK-UHFFFAOYSA-N 0.000 description 1
• OHUMNVUXCKGTDQ-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-(didodecylamino)ethyl-dodecylamino]ethyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCCCCC)N(CC(=O)N1CCN(CC1)CCN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CCCCCCCCCCCC)CCCCCCCCCCCC OHUMNVUXCKGTDQ-UHFFFAOYSA-N 0.000 description 1
• UGZREGJEOWUZFW-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-(didodecylamino)ethyl-nonylamino]acetyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCCCCC)N(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCC)CCN(CCCCCCCCCCCC)CCCCCCCCCCCC)=O)CCCCCCCCCCCC UGZREGJEOWUZFW-UHFFFAOYSA-N 0.000 description 1
• ALWRUWFADMKTRR-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-[di(nonyl)amino]ethyl-dodecylamino]acetyl]piperazin-1-yl]ethanone Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CC(=O)N1CCN(CC1)C(=O)CN(CCCCCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC ALWRUWFADMKTRR-UHFFFAOYSA-N 0.000 description 1
• WUVCFMGPLCSONQ-UHFFFAOYSA-N 2-(didodecylamino)-1-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]ethanone Chemical compound C(CCCCCCCCCCC)N(CC(=O)N1CCN(CC1)C(CN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)=O)CCCCCCCCCCCC WUVCFMGPLCSONQ-UHFFFAOYSA-N 0.000 description 1
• YQFRJTDYLIBDED-UHFFFAOYSA-N 2-(didodecylamino)ethanol Chemical compound CCCCCCCCCCCCN(CCO)CCCCCCCCCCCC YQFRJTDYLIBDED-UHFFFAOYSA-N 0.000 description 1
• BVLGKOVALHRKNM-XUTVFYLZSA-N 2-Thio-1-methylpseudouridine Chemical compound CN1C=C(C(=O)NC1=S)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O BVLGKOVALHRKNM-XUTVFYLZSA-N 0.000 description 1
• CWXIOHYALLRNSZ-JWMKEVCDSA-N 2-Thiodihydropseudouridine Chemical compound C1C(C(=O)NC(=S)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O CWXIOHYALLRNSZ-JWMKEVCDSA-N 0.000 description 1
• BFHHWEILVDOGCC-UHFFFAOYSA-N 2-[(11Z,14Z)-2-[3-(dimethylamino)propanoyloxy]icosa-11,14-dienoxy]ethyl (9Z,12Z)-octadeca-9,12-dienoate Chemical compound C(CCCCCCCC=C/CC=C/CCCCC)(=O)OCCOCC(CCCCCCCCC=C/CC=C/CCCCC)OC(CCN(C)C)=O BFHHWEILVDOGCC-UHFFFAOYSA-N 0.000 description 1
• SMFNOBBHYGDJRP-MAZCIEHSSA-N 2-[(9z,12z)-octadeca-9,12-dienoxy]-n-[2-[(9z,12z)-octadeca-9,12-dienoxy]ethyl]ethanamine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOCCNCCOCCCCCCCC\C=C/C\C=C/CCCCC SMFNOBBHYGDJRP-MAZCIEHSSA-N 0.000 description 1
• GAJTUMASULCSDK-KTKRTIGZSA-N 2-[(Z)-octadec-9-enoxy]benzamide Chemical compound C(CCCCCCC\C=C/CCCCCCCC)OC1=C(C(=O)N)C=CC=C1 GAJTUMASULCSDK-KTKRTIGZSA-N 0.000 description 1
• JVPCRRBCIFQOEG-KWXKLSQISA-N 2-[(dimethylamino)methyl]-3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-[[(9Z,12Z)-octadeca-9,12-dienoxy]methyl]propan-1-ol Chemical compound CN(CC(CO)(COCCCCCCCC\C=C/C\C=C/CCCCC)COCCCCCCCC\C=C/C\C=C/CCCCC)C JVPCRRBCIFQOEG-KWXKLSQISA-N 0.000 description 1
• VNAYNYLMGVVNPX-RYOQUFEFSA-N 2-[(z)-hexadec-9-enoxy]-n-[2-[(z)-hexadec-9-enoxy]ethyl]-n-methylethanamine Chemical compound CCCCCC\C=C/CCCCCCCCOCCN(C)CCOCCCCCCCC\C=C/CCCCCC VNAYNYLMGVVNPX-RYOQUFEFSA-N 0.000 description 1
• LRFJOIPOPUJUMI-KWXKLSQISA-N 2-[2,2-bis[(9z,12z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-n,n-dimethylethanamine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC1(CCCCCCCC\C=C/C\C=C/CCCCC)OCC(CCN(C)C)O1 LRFJOIPOPUJUMI-KWXKLSQISA-N 0.000 description 1
• GSHCNPAEDNETGJ-HKOLQMFGSA-N 2-[2,3-bis[[(z)-octadec-9-enoyl]oxy]propoxy-ethoxyphosphoryl]oxyethyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(=O)(OCC)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC GSHCNPAEDNETGJ-HKOLQMFGSA-N 0.000 description 1
• GUUGWGGRMYCWPW-UZYVYHOESA-N 2-[2-(didodecylamino)ethyl-[(Z)-dodec-6-enyl]amino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCN(CCO)CCCCC\C=C/CCCCC)CCCCCCCCCCCC GUUGWGGRMYCWPW-UZYVYHOESA-N 0.000 description 1
• CKYHXQVFYSCLRY-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-dodecylamino]-1-[4-[2-(didodecylamino)ethyl]piperazin-1-yl]ethanone Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CC(=O)N1CCN(CCN(CCCCCCCCCCCC)CCCCCCCCCCCC)CC1 CKYHXQVFYSCLRY-UHFFFAOYSA-N 0.000 description 1
• AGPPZXSUWFUCMR-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-dodecylamino]acetic acid Chemical compound C(CCCCCCCCCCC)N(CCN(CC(=O)O)CCCCCCCCCCCC)CCCCCCCCCCCC AGPPZXSUWFUCMR-UHFFFAOYSA-N 0.000 description 1
• XCUJNEGHISWZMR-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-hexylamino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCN(CCO)CCCCCC)CCCCCCCCCCCC XCUJNEGHISWZMR-UHFFFAOYSA-N 0.000 description 1
• IEZCEHHDPHPAER-UHFFFAOYSA-N 2-[2-(didodecylamino)ethyl-nonylamino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCN(CCO)CCCCCCCCC)CCCCCCCCCCCC IEZCEHHDPHPAER-UHFFFAOYSA-N 0.000 description 1
• NBYAZDHVBFXMCF-UHFFFAOYSA-N 2-[2-(didodecylamino)ethylamino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCNCCO)CCCCCCCCCCCC NBYAZDHVBFXMCF-UHFFFAOYSA-N 0.000 description 1
• DMGKQJLIOMPVSH-BBWANDEASA-N 2-[2-[bis[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethyl-[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethanol Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)N(CCN(CCO)CCCCCCCC\C=C/C\C=C/CCCCC)CCCCCCCC\C=C/C\C=C/CCCCC DMGKQJLIOMPVSH-BBWANDEASA-N 0.000 description 1
• XCGATPUUFSZPEU-ZBTSZJFVSA-N 2-[2-[bis[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethyl-dodecylamino]ethanol Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)N(CCN(CCO)CCCCCCCCCCCC)CCCCCCCC\C=C/C\C=C/CCCCC XCGATPUUFSZPEU-ZBTSZJFVSA-N 0.000 description 1
• KKHRANQBFXVJMF-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-dodecylamino]ethanol Chemical compound C(CCCCCCCC)N(CCN(CCO)CCCCCCCCCCCC)CCCCCCCCC KKHRANQBFXVJMF-UHFFFAOYSA-N 0.000 description 1
• XYPROMTWOHDKCL-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-nonylamino]-1-[3-[2-[di(nonyl)amino]ethyl]pyrrolidin-1-yl]ethanone Chemical compound C(CCCCCCCC)N(CCN(CC(=O)N1CC(CC1)CCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC)CCCCCCCCC XYPROMTWOHDKCL-UHFFFAOYSA-N 0.000 description 1
• SFWYWCBHACRKFJ-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-nonylamino]-1-[4-[2-[di(nonyl)amino]ethyl]piperidin-1-yl]ethanone Chemical compound C(CCCCCCCC)N(CCN(CC(=O)N1CCC(CC1)CCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC)CCCCCCCCC SFWYWCBHACRKFJ-UHFFFAOYSA-N 0.000 description 1
• JHMKJGRFJUTHKD-UHFFFAOYSA-N 2-[2-[di(nonyl)amino]ethyl-nonylamino]ethanol Chemical compound C(CCCCCCCC)N(CCN(CCO)CCCCCCCCC)CCCCCCCCC JHMKJGRFJUTHKD-UHFFFAOYSA-N 0.000 description 1
• UERKQTLROAQDCW-UHFFFAOYSA-N 2-[2-[di(tetradecyl)amino]ethyl-tetradecylamino]ethanol Chemical compound CCCCCCCCCCCCCCN(CCO)CCN(CCCCCCCCCCCCCC)CCCCCCCCCCCCCC UERKQTLROAQDCW-UHFFFAOYSA-N 0.000 description 1
• ITKKJJPJJIIAFQ-MAZCIEHSSA-N 2-[3,3-bis[(9Z,12Z)-octadeca-9,12-dienyl]azetidin-1-yl]ethanol Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)C1(CN(C1)CCO)CCCCCCCC\C=C/C\C=C/CCCCC ITKKJJPJJIIAFQ-MAZCIEHSSA-N 0.000 description 1
• NUBJGTNGKODGGX-YYNOVJQHSA-N 2-[5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-1-yl]acetic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CN(CC(O)=O)C(=O)NC1=O NUBJGTNGKODGGX-YYNOVJQHSA-N 0.000 description 1
• VJKJOPUEUOTEBX-TURQNECASA-N 2-[[1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]methylamino]ethanesulfonic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CNCCS(O)(=O)=O)=C1 VJKJOPUEUOTEBX-TURQNECASA-N 0.000 description 1
• ACLSRRFYJWTLTP-UHFFFAOYSA-N 2-[[3-(2-carboxy-10-octanoyloxydecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-10-octanoyloxydecanoic acid Chemical compound CCCCCCCC(=O)OCCCCCCCCC(Cc1cc(CC(CCCCCCCCOC(=O)CCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O ACLSRRFYJWTLTP-UHFFFAOYSA-N 0.000 description 1
• PWCAFUOPYQZCIU-UHFFFAOYSA-N 2-[[3-(2-carboxy-5-heptyldodecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-5-heptyldodecanoic acid Chemical compound CCCCCCCC(CCCCCCC)CCC(Cc1cc(CC(CCC(CCCCCCC)CCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O PWCAFUOPYQZCIU-UHFFFAOYSA-N 0.000 description 1
• SRTQWXPSXCNMOZ-UHFFFAOYSA-N 2-[[3-(2-carboxy-6-nonoxycarbonyloxyhexyl)-5-[(dimethylamino)methyl]phenyl]methyl]-6-nonoxycarbonyloxyhexanoic acid Chemical compound CCCCCCCCCOC(=O)OCCCCC(Cc1cc(CC(CCCCOC(=O)OCCCCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O SRTQWXPSXCNMOZ-UHFFFAOYSA-N 0.000 description 1
• INYWDMYBPAJGLJ-UHFFFAOYSA-N 2-[[3-(2-carboxy-7-hexyltridecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-7-hexyltridecanoic acid Chemical compound CCCCCCC(CCCCCC)CCCCC(Cc1cc(CC(CCCCC(CCCCCC)CCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O INYWDMYBPAJGLJ-UHFFFAOYSA-N 0.000 description 1
• OZTYEKYBNLSBOX-UHFFFAOYSA-N 2-[[3-(2-carboxy-8-octanoyloxyoctyl)-5-[(dimethylamino)methyl]phenyl]methyl]-8-octanoyloxyoctanoic acid Chemical compound CCCCCCCC(=O)OCCCCCCC(Cc1cc(CC(CCCCCCOC(=O)CCCCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O OZTYEKYBNLSBOX-UHFFFAOYSA-N 0.000 description 1
• BLAKABNCNOBITG-UHFFFAOYSA-N 2-[[3-(2-carboxy-9-pentyltetradecyl)-5-[(dimethylamino)methyl]phenyl]methyl]-9-pentyltetradecanoic acid Chemical compound CCCCCC(CCCCC)CCCCCCC(Cc1cc(CC(CCCCCCC(CCCCC)CCCCC)C(O)=O)cc(CN(C)C)c1)C(O)=O BLAKABNCNOBITG-UHFFFAOYSA-N 0.000 description 1
• LCKIHCRZXREOJU-KYXWUPHJSA-N 2-[[5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-1-yl]methylamino]ethanesulfonic acid Chemical compound C(NCCS(=O)(=O)O)N1C=C([C@H]2[C@H](O)[C@H](O)[C@@H](CO)O2)C(NC1=O)=O LCKIHCRZXREOJU-KYXWUPHJSA-N 0.000 description 1
• ONLQQRFLLHOAOH-UHFFFAOYSA-N 2-[di(nonyl)amino]-1-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]ethyl]piperidin-1-yl]ethanone Chemical compound C(CCCCCCCC)N(CC(=O)N1CCC(CC1)CCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC ONLQQRFLLHOAOH-UHFFFAOYSA-N 0.000 description 1
• UTQSJZGGDMBRSK-UHFFFAOYSA-N 2-[di(nonyl)amino]ethanol Chemical compound CCCCCCCCCN(CCO)CCCCCCCCC UTQSJZGGDMBRSK-UHFFFAOYSA-N 0.000 description 1
• DSFMICRLIRROMX-UHFFFAOYSA-N 2-[di(tetradecyl)amino]ethanol Chemical compound CCCCCCCCCCCCCCN(CCO)CCCCCCCCCCCCCC DSFMICRLIRROMX-UHFFFAOYSA-N 0.000 description 1
• VMKWCABNWIGNPN-BIXSNLIQSA-N 2-[dodecyl-[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethanol Chemical compound C(CCCCCCCCCCC)N(CCO)CCCCCCCC\C=C/C\C=C/CCCCC VMKWCABNWIGNPN-BIXSNLIQSA-N 0.000 description 1
• VROYQGBIVAQDEG-XVTLYKPTSA-N 2-[hexyl-[(9Z,12Z)-octadeca-9,12-dienyl]amino]ethanol Chemical compound C(CCCCC)N(CCO)CCCCCCCC\C=C/C\C=C/CCCCC VROYQGBIVAQDEG-XVTLYKPTSA-N 0.000 description 1
• CTPQMQZKRWLMRA-LYTXVXJPSA-N 2-amino-4-[5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methyl-2,6-dioxopyrimidin-1-yl]butanoic acid Chemical compound O=C1N(CCC(N)C(O)=O)C(=O)N(C)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 CTPQMQZKRWLMRA-LYTXVXJPSA-N 0.000 description 1
• MPDKOGQMQLSNOF-GBNDHIKLSA-N 2-amino-5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrimidin-6-one Chemical compound O=C1NC(N)=NC=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 MPDKOGQMQLSNOF-GBNDHIKLSA-N 0.000 description 1
• BIRQNXWAXWLATA-IOSLPCCCSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-1h-pyrrolo[2,3-d]pyrimidine-5-carbonitrile Chemical compound C1=C(C#N)C=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O BIRQNXWAXWLATA-IOSLPCCCSA-N 0.000 description 1
• OTDJAMXESTUWLO-UUOKFMHZSA-N 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-3H-purine-6-thione Chemical compound C12=NC(N)=NC(S)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OTDJAMXESTUWLO-UUOKFMHZSA-N 0.000 description 1
• IBKZHHCJWDWGAJ-FJGDRVTGSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methylpurine-6-thione Chemical compound C1=NC=2C(=S)N(C)C(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O IBKZHHCJWDWGAJ-FJGDRVTGSA-N 0.000 description 1
• HPKQEMIXSLRGJU-UUOKFMHZSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-3h-purine-6,8-dione Chemical compound O=C1N(C)C(C(NC(N)=N2)=O)=C2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HPKQEMIXSLRGJU-UUOKFMHZSA-N 0.000 description 1
• BGTXMQUSDNMLDW-AEHJODJJSA-N 2-amino-9-[(2r,3s,4r,5r)-3-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@]1(O)F BGTXMQUSDNMLDW-AEHJODJJSA-N 0.000 description 1
• PBFLIOAJBULBHI-JJNLEZRASA-N 2-amino-n-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]carbamoyl]acetamide Chemical compound C1=NC=2C(NC(=O)NC(=O)CN)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O PBFLIOAJBULBHI-JJNLEZRASA-N 0.000 description 1
• MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
• ZLGYVWRJIZPQMM-HHHXNRCGSA-N 2-azaniumylethyl [(2r)-2,3-di(dodecanoyloxy)propyl] phosphate Chemical compound CCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCC ZLGYVWRJIZPQMM-HHHXNRCGSA-N 0.000 description 1
• RLZMYTZDQAVNIN-ZOQUXTDFSA-N 2-methoxy-4-thio-uridine Chemical compound COC1=NC(=S)C=CN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O RLZMYTZDQAVNIN-ZOQUXTDFSA-N 0.000 description 1
• QCPQCJVQJKOKMS-VLSMUFELSA-N 2-methoxy-5-methyl-cytidine Chemical compound CC(C(N)=N1)=CN([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)C1OC QCPQCJVQJKOKMS-VLSMUFELSA-N 0.000 description 1
• TUDKBZAMOFJOSO-UHFFFAOYSA-N 2-methoxy-7h-purin-6-amine Chemical compound COC1=NC(N)=C2NC=NC2=N1 TUDKBZAMOFJOSO-UHFFFAOYSA-N 0.000 description 1
• STISOQJGVFEOFJ-MEVVYUPBSA-N 2-methoxy-cytidine Chemical compound COC(N([C@@H]([C@@H]1O)O[C@H](CO)[C@H]1O)C=C1)N=C1N STISOQJGVFEOFJ-MEVVYUPBSA-N 0.000 description 1
• WBVPJIKOWUQTSD-ZOQUXTDFSA-N 2-methoxyuridine Chemical compound COC1=NC(=O)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 WBVPJIKOWUQTSD-ZOQUXTDFSA-N 0.000 description 1
• VWSLLSXLURJCDF-UHFFFAOYSA-N 2-methyl-4,5-dihydro-1h-imidazole Chemical compound CC1=NCCN1 VWSLLSXLURJCDF-UHFFFAOYSA-N 0.000 description 1
• SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
• FZIIBDOXPQOKBP-UHFFFAOYSA-N 2-methyloxetane Chemical compound CC1CCO1 FZIIBDOXPQOKBP-UHFFFAOYSA-N 0.000 description 1
• FXGXEFXCWDTSQK-UHFFFAOYSA-N 2-methylsulfanyl-7h-purin-6-amine Chemical compound CSC1=NC(N)=C2NC=NC2=N1 FXGXEFXCWDTSQK-UHFFFAOYSA-N 0.000 description 1
• QEWSGVMSLPHELX-UHFFFAOYSA-N 2-methylthio-N6-(cis-hydroxyisopentenyl) adenosine Chemical compound C12=NC(SC)=NC(NCC=C(C)CO)=C2N=CN1C1OC(CO)C(O)C1O QEWSGVMSLPHELX-UHFFFAOYSA-N 0.000 description 1
• JUMHLCXWYQVTLL-KVTDHHQDSA-N 2-thio-5-aza-uridine Chemical compound [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C(=S)NC(=O)N=C1 JUMHLCXWYQVTLL-KVTDHHQDSA-N 0.000 description 1
• VRVXMIJPUBNPGH-XVFCMESISA-N 2-thio-dihydrouridine Chemical compound OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(=O)NC1=S VRVXMIJPUBNPGH-XVFCMESISA-N 0.000 description 1
• ZVGONGHIVBJXFC-WCTZXXKLSA-N 2-thio-zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)N=CC=C1 ZVGONGHIVBJXFC-WCTZXXKLSA-N 0.000 description 1
• RHFUOMFWUGWKKO-XVFCMESISA-N 2-thiocytidine Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RHFUOMFWUGWKKO-XVFCMESISA-N 0.000 description 1
• IPMGZOSVJWTBJN-UHFFFAOYSA-N 3-(2-octadecanoyloxyethylamino)propanoic acid Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)OCCNCCC(=O)O IPMGZOSVJWTBJN-UHFFFAOYSA-N 0.000 description 1
• YXNIEZJFCGTDKV-JANFQQFMSA-N 3-(3-amino-3-carboxypropyl)uridine Chemical compound O=C1N(CCC(N)C(O)=O)C(=O)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YXNIEZJFCGTDKV-JANFQQFMSA-N 0.000 description 1
• MVJKYYXKLCTVHV-UHFFFAOYSA-N 3-(didodecylamino)propan-1-ol Chemical compound CCCCCCCCCCCCN(CCCO)CCCCCCCCCCCC MVJKYYXKLCTVHV-UHFFFAOYSA-N 0.000 description 1
• RDPUKVRQKWBSPK-UHFFFAOYSA-N 3-Methylcytidine Natural products O=C1N(C)C(=N)C=CN1C1C(O)C(O)C(CO)O1 RDPUKVRQKWBSPK-UHFFFAOYSA-N 0.000 description 1
• DXEJZRDJXRVUPN-XUTVFYLZSA-N 3-Methylpseudouridine Chemical compound O=C1N(C)C(=O)NC=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DXEJZRDJXRVUPN-XUTVFYLZSA-N 0.000 description 1
• UTQUILVPBZEHTK-UHFFFAOYSA-N 3-Methyluridine Natural products O=C1N(C)C(=O)C=CN1C1C(O)C(O)C(CO)O1 UTQUILVPBZEHTK-UHFFFAOYSA-N 0.000 description 1
• HOEIPINIBKBXTJ-IDTAVKCVSA-N 3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6,7-trimethylimidazo[1,2-a]purin-9-one Chemical compound C1=NC=2C(=O)N3C(C)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HOEIPINIBKBXTJ-IDTAVKCVSA-N 0.000 description 1
• DIIXYZRGUJMAPE-KWXKLSQISA-N 3-[(6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl]oxy-n,n-dimethylpropan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(OCCCN(C)C)CCCCCCCC\C=C/C\C=C/CCCCC DIIXYZRGUJMAPE-KWXKLSQISA-N 0.000 description 1
• QMUKEIDLGNKIKN-MAZCIEHSSA-N 3-[1,3-bis[[(9Z,12Z)-octadeca-9,12-dienoyl]oxy]propan-2-ylamino]propanoic acid Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)OCC(COC(CCCCCCC\C=C/C\C=C/CCCCC)=O)NCCC(=O)O QMUKEIDLGNKIKN-MAZCIEHSSA-N 0.000 description 1
• RIQHMABUWMQZJV-UHFFFAOYSA-N 3-[2-(didodecylamino)ethyl-dodecylamino]propan-1-ol Chemical compound CCCCCCCCCCCCN(CCCO)CCN(CCCCCCCCCCCC)CCCCCCCCCCCC RIQHMABUWMQZJV-UHFFFAOYSA-N 0.000 description 1
• UDFFIGDHAYXXDS-HZJYTTRNSA-N 3-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxyethylamino]propanoic acid Chemical compound C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)OCCNCCC(=O)O UDFFIGDHAYXXDS-HZJYTTRNSA-N 0.000 description 1
• DTKDRZRIPYITIW-KTKRTIGZSA-N 3-[2-[(Z)-octadec-9-enoyl]oxyethylamino]propanoic acid Chemical compound C(CCCCCCC\C=C/CCCCCCCC)(=O)OCCNCCC(=O)O DTKDRZRIPYITIW-KTKRTIGZSA-N 0.000 description 1
• CDUMGCQRSJBAON-UHFFFAOYSA-N 3-[2-[di(nonyl)amino]ethyl-nonylamino]-1-[4-[3-[di(nonyl)amino]propyl]piperidin-1-yl]propan-1-one Chemical compound C(CCCCCCCC)N(CCN(CCC(=O)N1CCC(CC1)CCCN(CCCCCCCCC)CCCCCCCCC)CCCCCCCCC)CCCCCCCCC CDUMGCQRSJBAON-UHFFFAOYSA-N 0.000 description 1
• KKMJGOWNIFWYSL-UHFFFAOYSA-N 3-[2-[di(tetradecyl)amino]ethyl-dodecylamino]propan-1-ol Chemical compound C(CCCCCCCCCCCCC)N(CCN(CCCO)CCCCCCCCCCCC)CCCCCCCCCCCCCC KKMJGOWNIFWYSL-UHFFFAOYSA-N 0.000 description 1
• AHVZCQRHQQHWJC-UHFFFAOYSA-N 3-[3-[1-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperidin-4-yl]propyl-nonylamino]propyl hexanoate Chemical compound C(CCCCC)(=O)OCCCN(CCCCCCCCC)CCCC1CCN(CC1)C(CCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)=O AHVZCQRHQQHWJC-UHFFFAOYSA-N 0.000 description 1
• BVZVICBYYOYVEP-MAZCIEHSSA-N 3-[bis[(9z,12z)-octadeca-9,12-dienyl]amino]propane-1,2-diol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCN(CC(O)CO)CCCCCCCC\C=C/C\C=C/CCCCC BVZVICBYYOYVEP-MAZCIEHSSA-N 0.000 description 1
• KGGMQGNIHKULJB-CLFAGFIQSA-N 3-[bis[(z)-octadec-9-enyl]amino]propan-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCN(CCCO)CCCCCCCC\C=C/CCCCCCCC KGGMQGNIHKULJB-CLFAGFIQSA-N 0.000 description 1
• KINYKGGRZOKATB-UHFFFAOYSA-N 3-[di(nonyl)amino]-1-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]propan-1-one Chemical compound CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CCC(=O)N1CCN(CC1)C(=O)CCN(CCCCCCCCC)CCCCCCCCC KINYKGGRZOKATB-UHFFFAOYSA-N 0.000 description 1
• RDPUKVRQKWBSPK-ZOQUXTDFSA-N 3-methylcytidine Chemical compound O=C1N(C)C(=N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RDPUKVRQKWBSPK-ZOQUXTDFSA-N 0.000 description 1
• 101800000535 3C-like proteinase Proteins 0.000 description 1
• 101800002396 3C-like proteinase nsp5 Proteins 0.000 description 1
• 101800001631 3C-like serine proteinase Proteins 0.000 description 1
• FYNLRTWMACAXIY-UHFFFAOYSA-N 3H-dioxol-3-amine Chemical compound NC1OOC=C1 FYNLRTWMACAXIY-UHFFFAOYSA-N 0.000 description 1
• IXUGVJKHVCCUDB-UHFFFAOYSA-N 4-(didodecylamino)butan-1-ol Chemical compound CCCCCCCCCCCCN(CCCCO)CCCCCCCCCCCC IXUGVJKHVCCUDB-UHFFFAOYSA-N 0.000 description 1
• ZSIINYPBPQCZKU-BQNZPOLKSA-O 4-Methoxy-1-methylpseudoisocytidine Chemical compound C[N+](CC1[C@H]([C@H]2O)O[C@@H](CO)[C@@H]2O)=C(N)N=C1OC ZSIINYPBPQCZKU-BQNZPOLKSA-O 0.000 description 1
• FGFVODMBKZRMMW-XUTVFYLZSA-N 4-Methoxy-2-thiopseudouridine Chemical compound COC1=C(C=NC(=S)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O FGFVODMBKZRMMW-XUTVFYLZSA-N 0.000 description 1
• HOCJTJWYMOSXMU-XUTVFYLZSA-N 4-Methoxypseudouridine Chemical compound COC1=C(C=NC(=O)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O HOCJTJWYMOSXMU-XUTVFYLZSA-N 0.000 description 1
• VTGBLFNEDHVUQA-XUTVFYLZSA-N 4-Thio-1-methyl-pseudouridine Chemical compound S=C1NC(=O)N(C)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 VTGBLFNEDHVUQA-XUTVFYLZSA-N 0.000 description 1
• DMUQOPXCCOBPID-XUTVFYLZSA-N 4-Thio-1-methylpseudoisocytidine Chemical compound CN1C=C(C(=S)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O DMUQOPXCCOBPID-XUTVFYLZSA-N 0.000 description 1
• ZLOIGESWDJYCTF-UHFFFAOYSA-N 4-Thiouridine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-UHFFFAOYSA-N 0.000 description 1
• HTROZTWMNIUSTF-UHFFFAOYSA-N 4-[2-(didodecylamino)ethyl-dodecylamino]butan-1-ol Chemical compound C(CCCCCCCCCCC)N(CCN(CCCCO)CCCCCCCCCCCC)CCCCCCCCCCCC HTROZTWMNIUSTF-UHFFFAOYSA-N 0.000 description 1
• OCMSXKMNYAHJMU-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidine-5-carbaldehyde Chemical compound C1=C(C=O)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OCMSXKMNYAHJMU-JXOAFFINSA-N 0.000 description 1
• LQQGJDJXUSAEMZ-UAKXSSHOSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one Chemical compound C1=C(I)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LQQGJDJXUSAEMZ-UAKXSSHOSA-N 0.000 description 1
• OZHIJZYBTCTDQC-JXOAFFINSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2-thione Chemical compound S=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OZHIJZYBTCTDQC-JXOAFFINSA-N 0.000 description 1
• PJWBTAIPBFWVHX-FJGDRVTGSA-N 4-amino-1-[(2r,3s,4r,5r)-3-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@](F)(O)[C@H](O)[C@@H](CO)O1 PJWBTAIPBFWVHX-FJGDRVTGSA-N 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
• GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
• LOICBOXHPCURMU-UHFFFAOYSA-N 4-methoxy-pseudoisocytidine Chemical compound COC1NC(N)=NC=C1C(C1O)OC(CO)C1O LOICBOXHPCURMU-UHFFFAOYSA-N 0.000 description 1
• SJVVKUMXGIKAAI-UHFFFAOYSA-N 4-thio-pseudoisocytidine Chemical compound NC(N1)=NC=C(C(C2O)OC(CO)C2O)C1=S SJVVKUMXGIKAAI-UHFFFAOYSA-N 0.000 description 1
• ZLOIGESWDJYCTF-XVFCMESISA-N 4-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-XVFCMESISA-N 0.000 description 1
• FAWQJBLSWXIJLA-VPCXQMTMSA-N 5-(carboxymethyl)uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CC(O)=O)=C1 FAWQJBLSWXIJLA-VPCXQMTMSA-N 0.000 description 1
• NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 description 1
• NFEXJLMYXXIWPI-JXOAFFINSA-N 5-Hydroxymethylcytidine Chemical compound C1=C(CO)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NFEXJLMYXXIWPI-JXOAFFINSA-N 0.000 description 1
• ZAYHVCMSTBRABG-UHFFFAOYSA-N 5-Methylcytidine Natural products O=C1N=C(N)C(C)=CN1C1C(O)C(O)C(CO)O1 ZAYHVCMSTBRABG-UHFFFAOYSA-N 0.000 description 1
• ZYEWPVTXYBLWRT-UHFFFAOYSA-N 5-Uridinacetamid Natural products O=C1NC(=O)C(CC(=O)N)=CN1C1C(O)C(O)C(CO)O1 ZYEWPVTXYBLWRT-UHFFFAOYSA-N 0.000 description 1
• ITGWEVGJUSMCEA-KYXWUPHJSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)N(C#CC)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ITGWEVGJUSMCEA-KYXWUPHJSA-N 0.000 description 1
• DDHOXEOVAJVODV-GBNDHIKLSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=S)NC1=O DDHOXEOVAJVODV-GBNDHIKLSA-N 0.000 description 1
• BNAWMJKJLNJZFU-GBNDHIKLSA-N 5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidene-1h-pyrimidin-2-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=S BNAWMJKJLNJZFU-GBNDHIKLSA-N 0.000 description 1
• OZQDLJNDRVBCST-SHUUEZRQSA-N 5-amino-2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazin-3-one Chemical compound O=C1N=C(N)C=NN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 OZQDLJNDRVBCST-SHUUEZRQSA-N 0.000 description 1
• XUNBIDXYAUXNKD-DBRKOABJSA-N 5-aza-2-thio-zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)N=CN=C1 XUNBIDXYAUXNKD-DBRKOABJSA-N 0.000 description 1
• OSLBPVOJTCDNEF-DBRKOABJSA-N 5-aza-zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=CN=C1 OSLBPVOJTCDNEF-DBRKOABJSA-N 0.000 description 1
• NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
• AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
• ZYEWPVTXYBLWRT-VPCXQMTMSA-N 5-carbamoylmethyluridine Chemical compound O=C1NC(=O)C(CC(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZYEWPVTXYBLWRT-VPCXQMTMSA-N 0.000 description 1
• VKLFQTYNHLDMDP-PNHWDRBUSA-N 5-carboxymethylaminomethyl-2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C(CNCC(O)=O)=C1 VKLFQTYNHLDMDP-PNHWDRBUSA-N 0.000 description 1
• QJRZJUYDULYQPX-UHFFFAOYSA-N 5-heptyldodecanoic acid Chemical compound CCCCCCCC(CCCC(O)=O)CCCCCCC QJRZJUYDULYQPX-UHFFFAOYSA-N 0.000 description 1
• ZXIATBNUWJBBGT-JXOAFFINSA-N 5-methoxyuridine Chemical compound O=C1NC(=O)C(OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZXIATBNUWJBBGT-JXOAFFINSA-N 0.000 description 1
• KBDWGFZSICOZSJ-UHFFFAOYSA-N 5-methyl-2,3-dihydro-1H-pyrimidin-4-one Chemical compound N1CNC=C(C1=O)C KBDWGFZSICOZSJ-UHFFFAOYSA-N 0.000 description 1
• ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
• SNNBPMAXGYBMHM-JXOAFFINSA-N 5-methyl-2-thiouridine Chemical compound S=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 SNNBPMAXGYBMHM-JXOAFFINSA-N 0.000 description 1
• RPQQZHJQUBDHHG-FNCVBFRFSA-N 5-methyl-zebularine Chemical compound C1=C(C)C=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RPQQZHJQUBDHHG-FNCVBFRFSA-N 0.000 description 1
• ZXQHKBUIXRFZBV-FDDDBJFASA-N 5-methylaminomethyluridine Chemical compound O=C1NC(=O)C(CNC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZXQHKBUIXRFZBV-FDDDBJFASA-N 0.000 description 1
• ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 description 1
• UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
• OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
• USVMJSALORZVDV-UHFFFAOYSA-N 6-(gamma,gamma-dimethylallylamino)purine riboside Natural products C1=NC=2C(NCC=C(C)C)=NC=NC=2N1C1OC(CO)C(O)C1O USVMJSALORZVDV-UHFFFAOYSA-N 0.000 description 1
• ZKBQDFAWXLTYKS-UHFFFAOYSA-N 6-Chloro-1H-purine Chemical compound ClC1=NC=NC2=C1NC=N2 ZKBQDFAWXLTYKS-UHFFFAOYSA-N 0.000 description 1
• OZTOEARQSSIFOG-MWKIOEHESA-N 6-Thio-7-deaza-8-azaguanosine Chemical compound Nc1nc(=S)c2cnn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1 OZTOEARQSSIFOG-MWKIOEHESA-N 0.000 description 1
• KXBCLNRMQPRVTP-UHFFFAOYSA-N 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one Chemical compound O=C1NC(N)=CC2=C1N=CN2 KXBCLNRMQPRVTP-UHFFFAOYSA-N 0.000 description 1
• DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
• WYXSYVWAUAUWLD-SHUUEZRQSA-N 6-azauridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=N1 WYXSYVWAUAUWLD-SHUUEZRQSA-N 0.000 description 1
• RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 description 1
• AFWWNHLDHNSVSD-UHFFFAOYSA-N 6-methyl-7h-purin-2-amine Chemical compound CC1=NC(N)=NC2=C1NC=N2 AFWWNHLDHNSVSD-UHFFFAOYSA-N 0.000 description 1
• CBNRZZNSRJQZNT-IOSLPCCCSA-O 6-thio-7-deaza-guanosine Chemical compound CC1=C[NH+]([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)C(NC(N)=N2)=C1C2=S CBNRZZNSRJQZNT-IOSLPCCCSA-O 0.000 description 1
• RFHIWBUKNJIBSE-KQYNXXCUSA-O 6-thio-7-methyl-guanosine Chemical compound C1=2NC(N)=NC(=S)C=2N(C)C=[N+]1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RFHIWBUKNJIBSE-KQYNXXCUSA-O 0.000 description 1
• MJJUWOIBPREHRU-MWKIOEHESA-N 7-Deaza-8-azaguanosine Chemical compound NC=1NC(C2=C(N=1)N(N=C2)[C@H]1[C@H](O)[C@H](O)[C@H](O1)CO)=O MJJUWOIBPREHRU-MWKIOEHESA-N 0.000 description 1
• FMKSMYDYKXQYRV-UHFFFAOYSA-N 7-cyano-7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1C(C#N)=CN2 FMKSMYDYKXQYRV-UHFFFAOYSA-N 0.000 description 1
• ISSMDAFGDCTNDV-UHFFFAOYSA-N 7-deaza-2,6-diaminopurine Chemical compound NC1=NC(N)=C2NC=CC2=N1 ISSMDAFGDCTNDV-UHFFFAOYSA-N 0.000 description 1
• YVVMIGRXQRPSIY-UHFFFAOYSA-N 7-deaza-2-aminopurine Chemical compound N1C(N)=NC=C2C=CN=C21 YVVMIGRXQRPSIY-UHFFFAOYSA-N 0.000 description 1
• ZTAWTRPFJHKMRU-UHFFFAOYSA-N 7-deaza-8-aza-2,6-diaminopurine Chemical compound NC1=NC(N)=C2NN=CC2=N1 ZTAWTRPFJHKMRU-UHFFFAOYSA-N 0.000 description 1
• SMXRCJBCWRHDJE-UHFFFAOYSA-N 7-deaza-8-aza-2-aminopurine Chemical compound NC1=NC=C2C=NNC2=N1 SMXRCJBCWRHDJE-UHFFFAOYSA-N 0.000 description 1
• LHCPRYRLDOSKHK-UHFFFAOYSA-N 7-deaza-8-aza-adenine Chemical compound NC1=NC=NC2=C1C=NN2 LHCPRYRLDOSKHK-UHFFFAOYSA-N 0.000 description 1
• LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
• ZVDWKWBEIOEXQK-UHFFFAOYSA-N 7-hexyltridecanoic acid Chemical compound CCCCCCC(CCCCCC)CCCCCC(O)=O ZVDWKWBEIOEXQK-UHFFFAOYSA-N 0.000 description 1
• OGHAROSJZRTIOK-KQYNXXCUSA-O 7-methylguanosine Chemical compound C1=2N=C(N)NC(=O)C=2[N+](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-O 0.000 description 1
• VJNXUFOTKNTNPG-IOSLPCCCSA-O 7-methylinosine Chemical compound C1=2NC=NC(=O)C=2N(C)C=[N+]1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VJNXUFOTKNTNPG-IOSLPCCCSA-O 0.000 description 1
• HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical compound NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 1
• LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
• 229960005508 8-azaguanine Drugs 0.000 description 1
• ADPMAYFIIFNDMT-KQYNXXCUSA-N 9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(methylamino)-3h-purine-6-thione Chemical compound C1=NC=2C(=S)NC(NC)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ADPMAYFIIFNDMT-KQYNXXCUSA-N 0.000 description 1
• OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
• JGAJDHRXKJAGLF-UHFFFAOYSA-N 9-pentyltetradecanoic acid Chemical compound C(CCCC)C(CCCCCCCC(=O)O)CCCCC JGAJDHRXKJAGLF-UHFFFAOYSA-N 0.000 description 1
• IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
• 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 1
• 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 1
• 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 1
• 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 1
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 208000010470 Ageusia Diseases 0.000 description 1
• 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 1
• 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 1
• 206010002653 Anosmia Diseases 0.000 description 1
• 108010085443 Anserine Proteins 0.000 description 1
• PEMQXWCOMFJRLS-UHFFFAOYSA-N Archaeosine Natural products C1=2NC(N)=NC(=O)C=2C(C(=N)N)=CN1C1OC(CO)C(O)C1O PEMQXWCOMFJRLS-UHFFFAOYSA-N 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
• 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 1
• 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 1
• 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 1
• 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 1
• 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 1
• 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 1
• 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 1
• 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• QSXYZCXVYQFQAV-UHFFFAOYSA-N C(CCCCCCCCCCCCC)C(N(C)C)CCCCCCCCCCCCCC Chemical compound C(CCCCCCCCCCCCC)C(N(C)C)CCCCCCCCCCCCCC QSXYZCXVYQFQAV-UHFFFAOYSA-N 0.000 description 1
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
• IXTUSQSJHKRGGL-UHFFFAOYSA-N CCCCCCCC(OCCCCCCC(CC(CC(CCCCCCOC(CCCCCCC)=O)C(O)=O)COC(C1(C)CN(C)CC1)=O)C(O)=O)=O Chemical compound CCCCCCCC(OCCCCCCC(CC(CC(CCCCCCOC(CCCCCCC)=O)C(O)=O)COC(C1(C)CN(C)CC1)=O)C(O)=O)=O IXTUSQSJHKRGGL-UHFFFAOYSA-N 0.000 description 1
• ZPGOFQMJAGSCMT-VYEFPUSRSA-N CCCCCCCCC(CCCCCCCC)CC(CCCCC(CCCCCC/C=C\C/C=C\CCCCC)C(=O)O)OC(=O)OCCCN(C)C Chemical compound CCCCCCCCC(CCCCCCCC)CC(CCCCC(CCCCCC/C=C\C/C=C\CCCCC)C(=O)O)OC(=O)OCCCN(C)C ZPGOFQMJAGSCMT-VYEFPUSRSA-N 0.000 description 1
• GPHNNLAMKGYYIX-UHFFFAOYSA-N CCCCCCCCCC(CCCCCCC)(CC(CC(CCCCCCC)(CCCCCCCCC)C(O)=O)COC(OCCCN(C)C)=O)C(O)=O Chemical compound CCCCCCCCCC(CCCCCCC)(CC(CC(CCCCCCC)(CCCCCCCCC)C(O)=O)COC(OCCCN(C)C)=O)C(O)=O GPHNNLAMKGYYIX-UHFFFAOYSA-N 0.000 description 1
• YOOJWLXBZWGGFW-UHFFFAOYSA-N CCCCCCCCCCCCC(CCC(OC(CCCCCCCCCCC(O)=O)CCCCCCCCCCC(O)=O)=O)OC(OCCCN(C)CC)=O Chemical compound CCCCCCCCCCCCC(CCC(OC(CCCCCCCCCCC(O)=O)CCCCCCCCCCC(O)=O)=O)OC(OCCCN(C)CC)=O YOOJWLXBZWGGFW-UHFFFAOYSA-N 0.000 description 1
• BLIPNMXZHIPUOI-OIRSPXBMSA-N CCN(CC)CCC(OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)=O Chemical compound CCN(CC)CCC(OCC(CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)CCCCCC/C=C\C/C=C\CCCCCCCC(O)=O)=O BLIPNMXZHIPUOI-OIRSPXBMSA-N 0.000 description 1
• PCBZRNYXXCIELG-WYFCWLEVSA-N COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 Chemical compound COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 PCBZRNYXXCIELG-WYFCWLEVSA-N 0.000 description 1
• 229940022962 COVID-19 vaccine Drugs 0.000 description 1
• 101100236724 Caenorhabditis elegans mcm-5 gene Proteins 0.000 description 1
• 101000909256 Caldicellulosiruptor bescii (strain ATCC BAA-1888 / DSM 6725 / Z-1320) DNA polymerase I Proteins 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
• 108010087806 Carnosine Proteins 0.000 description 1
• 108091005462 Cation channels Proteins 0.000 description 1
• 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 108700002099 Coronavirus Nucleocapsid Proteins Proteins 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
• CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
• 108010041986 DNA Vaccines Proteins 0.000 description 1
• 230000009946 DNA mutation Effects 0.000 description 1
• 102000004214 DNA polymerase A Human genes 0.000 description 1
• 108090000725 DNA polymerase A Proteins 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 229940021995 DNA vaccine Drugs 0.000 description 1
• XULFJDKZVHTRLG-JDVCJPALSA-N DOSPA trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F.CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)CCNC(=O)C(CCCNCCCN)NCCCN)OCCCCCCCC\C=C/CCCCCCCC XULFJDKZVHTRLG-JDVCJPALSA-N 0.000 description 1
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• YKWUPFSEFXSGRT-JWMKEVCDSA-N Dihydropseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1C(=O)NC(=O)NC1 YKWUPFSEFXSGRT-JWMKEVCDSA-N 0.000 description 1
• 101100226146 Drosophila mojavensis Est-5 gene Proteins 0.000 description 1
• 208000000059 Dyspnea Diseases 0.000 description 1
• 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 1
• 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• 101710091918 Eukaryotic translation initiation factor 4E Proteins 0.000 description 1
• 102100027304 Eukaryotic translation initiation factor 4E Human genes 0.000 description 1
• 101710126428 Eukaryotic translation initiation factor 4E-2 Proteins 0.000 description 1
• 101710126416 Eukaryotic translation initiation factor 4E-3 Proteins 0.000 description 1
• 101710126432 Eukaryotic translation initiation factor 4E1 Proteins 0.000 description 1
• 101710133325 Eukaryotic translation initiation factor NCBP Proteins 0.000 description 1
• 101710190212 Eukaryotic translation initiation factor isoform 4E Proteins 0.000 description 1
• 101710124729 Eukaryotic translation initiation factor isoform 4E-2 Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 1
• 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 1
• JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 101800001704 Guanine-N7 methyltransferase Proteins 0.000 description 1
• 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 1
• 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 1
• 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
• 206010019233 Headaches Diseases 0.000 description 1
• 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
• 108010042653 IgA receptor Proteins 0.000 description 1
• 102220637433 Inorganic pyrophosphatase_T11I_mutation Human genes 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000000588 Interleukin-2 Human genes 0.000 description 1
• 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 1
• 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 1
• 229910007966 Li-Co Inorganic materials 0.000 description 1
• 229910008295 Li—Co Inorganic materials 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 1
• 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 1
• 241000282339 Mustela Species 0.000 description 1
• 208000000112 Myalgia Diseases 0.000 description 1
• 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 1
• RSPURTUNRHNVGF-IOSLPCCCSA-N N(2),N(2)-dimethylguanosine Chemical compound C1=NC=2C(=O)NC(N(C)C)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RSPURTUNRHNVGF-IOSLPCCCSA-N 0.000 description 1
• SLEHROROQDYRAW-KQYNXXCUSA-N N(2)-methylguanosine Chemical compound C1=NC=2C(=O)NC(NC)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O SLEHROROQDYRAW-KQYNXXCUSA-N 0.000 description 1
• NIDVTARKFBZMOT-PEBGCTIMSA-N N(4)-acetylcytidine Chemical compound O=C1N=C(NC(=O)C)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NIDVTARKFBZMOT-PEBGCTIMSA-N 0.000 description 1
• WVGPGNPCZPYCLK-WOUKDFQISA-N N(6),N(6)-dimethyladenosine Chemical compound C1=NC=2C(N(C)C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WVGPGNPCZPYCLK-WOUKDFQISA-N 0.000 description 1
• USVMJSALORZVDV-SDBHATRESA-N N(6)-(Delta(2)-isopentenyl)adenosine Chemical compound C1=NC=2C(NCC=C(C)C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O USVMJSALORZVDV-SDBHATRESA-N 0.000 description 1
• MWHHYFRYDBRJGP-UHFFFAOYSA-N N,N,N'-tri(nonyl)-N'-(2-piperazin-1-ylethyl)ethane-1,2-diamine Chemical compound C(CCCCCCCC)N(CCN(CCN1CCNCC1)CCCCCCCCC)CCCCCCCCC MWHHYFRYDBRJGP-UHFFFAOYSA-N 0.000 description 1
• UUEKLNVMPZZRBG-UHFFFAOYSA-N N,N,N'-tridodecyl-N'-(2-piperazin-1-ylethyl)ethane-1,2-diamine Chemical compound C(CCCCCCCCCCC)N(CCN(CCN1CCNCC1)CCCCCCCCCCCC)CCCCCCCCCCCC UUEKLNVMPZZRBG-UHFFFAOYSA-N 0.000 description 1
• MNSMRRBZJIPOPZ-UHFFFAOYSA-N N,N,N'-trihexyl-N'-(2-piperazin-1-ylethyl)ethane-1,2-diamine Chemical compound CCCCCCN(CCCCCC)CCN(CCCCCC)CCN1CCNCC1 MNSMRRBZJIPOPZ-UHFFFAOYSA-N 0.000 description 1
• WVGPGNPCZPYCLK-UHFFFAOYSA-N N-Dimethyladenosine Natural products C1=NC=2C(N(C)C)=NC=NC=2N1C1OC(CO)C(O)C1O WVGPGNPCZPYCLK-UHFFFAOYSA-N 0.000 description 1
• UNUYMBPXEFMLNW-DWVDDHQFSA-N N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine Chemical compound C1=NC=2C(NC(=O)N[C@@H]([C@H](O)C)C(O)=O)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UNUYMBPXEFMLNW-DWVDDHQFSA-N 0.000 description 1
• LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Chemical compound C=1C=C(C#N)C(C(F)(F)F)=CC=1NC(=O)C(O)(C)CS(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-UHFFFAOYSA-N 0.000 description 1
• SLLVJTURCPWLTP-UHFFFAOYSA-N N-[9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]acetamide Chemical compound C1=NC=2C(NC(=O)C)=NC=NC=2N1C1OC(CO)C(O)C1O SLLVJTURCPWLTP-UHFFFAOYSA-N 0.000 description 1
• CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
• XEIMJDMWIZORAY-UHFFFAOYSA-N N-dodecyl-N-(2-piperazin-1-ylethyl)dodecan-1-amine Chemical compound C(CCCCCCCCCCC)N(CCN1CCNCC1)CCCCCCCCCCCC XEIMJDMWIZORAY-UHFFFAOYSA-N 0.000 description 1
• RIUSOEYVJCYOOF-UHFFFAOYSA-N N-dodecyl-N-[2-[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]ethyl]dodecan-1-amine Chemical compound C(CCCCCCCCCCC)N(CCCCCCCCCCCC)CCN1CCN(CC1)CC1=CC=C(C=C1)OC RIUSOEYVJCYOOF-UHFFFAOYSA-N 0.000 description 1
• 230000004988 N-glycosylation Effects 0.000 description 1
• CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
• JCVDHQZATRGRQF-UHFFFAOYSA-N N-nonyl-N-(2-piperazin-1-ylethyl)nonan-1-amine Chemical compound C(CCCCCCCC)N(CCCCCCCCC)CCN1CCNCC1 JCVDHQZATRGRQF-UHFFFAOYSA-N 0.000 description 1
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
• LZCNWAXLJWBRJE-ZOQUXTDFSA-N N4-Methylcytidine Chemical compound O=C1N=C(NC)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 LZCNWAXLJWBRJE-ZOQUXTDFSA-N 0.000 description 1
• GOSWTRUMMSCNCW-UHFFFAOYSA-N N6-(cis-hydroxyisopentenyl)adenosine Chemical compound C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1OC(CO)C(O)C1O GOSWTRUMMSCNCW-UHFFFAOYSA-N 0.000 description 1
• VQAYFKKCNSOZKM-UHFFFAOYSA-N NSC 29409 Natural products C1=NC=2C(NC)=NC=NC=2N1C1OC(CO)C(O)C1O VQAYFKKCNSOZKM-UHFFFAOYSA-N 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 101800000515 Non-structural protein 3 Proteins 0.000 description 1
• 101800000514 Non-structural protein 4 Proteins 0.000 description 1
• 101800000508 Non-structural protein 5 Proteins 0.000 description 1
• 101800000507 Non-structural protein 6 Proteins 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• VZQXUWKZDSEQRR-UHFFFAOYSA-N Nucleosid Natural products C12=NC(SC)=NC(NCC=C(C)C)=C2N=CN1C1OC(CO)C(O)C1O VZQXUWKZDSEQRR-UHFFFAOYSA-N 0.000 description 1
• JXNORPPTKDEAIZ-QOCRDCMYSA-N O-4''-alpha-D-mannosylqueuosine Chemical compound NC(N1)=NC(N([C@@H]([C@@H]2O)O[C@H](CO)[C@H]2O)C=C2CN[C@H]([C@H]3O)C=C[C@@H]3O[C@H]([C@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)=C2C1=O JXNORPPTKDEAIZ-QOCRDCMYSA-N 0.000 description 1
• 101710193592 ORF3a protein Proteins 0.000 description 1
• 108700022034 Opsonin Proteins Proteins 0.000 description 1
• 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 1
• 206010068319 Oropharyngeal pain Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 101800004803 Papain-like protease Proteins 0.000 description 1
• 101800002227 Papain-like protease nsp3 Proteins 0.000 description 1
• 101800001074 Papain-like proteinase Proteins 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
• 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
• 208000005228 Pericardial Effusion Diseases 0.000 description 1
• 201000007100 Pharyngitis Diseases 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
• 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 102000015623 Polynucleotide Adenylyltransferase Human genes 0.000 description 1
• 108010024055 Polynucleotide adenylyltransferase Proteins 0.000 description 1
• 241000210053 Potentilla elegans Species 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
• 101800001862 Proofreading exoribonuclease Proteins 0.000 description 1
• 101800002929 Proofreading exoribonuclease nsp14 Proteins 0.000 description 1
• 102000007327 Protamines Human genes 0.000 description 1
• 108010007568 Protamines Proteins 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101710194807 Protective antigen Proteins 0.000 description 1
• 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 1
• 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 1
• 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 1
• 229930185560 Pseudouridine Natural products 0.000 description 1
• PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 1
• 101800001255 Putative 2'-O-methyl transferase Proteins 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 101000902592 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) DNA polymerase Proteins 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
• 101800004575 RNA-directed RNA polymerase nsp12 Proteins 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
• 208000036071 Rhinorrhea Diseases 0.000 description 1
• 206010039101 Rhinorrhoea Diseases 0.000 description 1
• 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 1
• 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 1
• 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000315672 SARS coronavirus Species 0.000 description 1
• 108091006197 SARS-CoV-2 Nucleocapsid Protein Proteins 0.000 description 1
• 208000037847 SARS-CoV-2-infection Diseases 0.000 description 1
• 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 101001024637 Severe acute respiratory syndrome coronavirus 2 Nucleoprotein Proteins 0.000 description 1
• 101000970479 Severe acute respiratory syndrome coronavirus 2 ORF8 protein Proteins 0.000 description 1
• 102220599612 Spindlin-1_A701V_mutation Human genes 0.000 description 1
• 102220599632 Spindlin-1_F888L_mutation Human genes 0.000 description 1
• 102220590696 Spindlin-1_G142D_mutation Human genes 0.000 description 1
• 102220599673 Spindlin-1_H655Y_mutation Human genes 0.000 description 1
• 102220599629 Spindlin-1_Q1071H_mutation Human genes 0.000 description 1
• 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 1
• 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 1
• 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 1
• 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 101710137500 T7 RNA polymerase Proteins 0.000 description 1
• 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 1
• 241000589500 Thermus aquaticus Species 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 108091046915 Threose nucleic acid Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 101710198378 Uncharacterized 10.8 kDa protein in cox-rep intergenic region Proteins 0.000 description 1
• 101800000578 Uridylate-specific endoribonuclease Proteins 0.000 description 1
• 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 1
• 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 1
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
• 230000010530 Virus Neutralization Effects 0.000 description 1
• 102220506816 Vitelline membrane outer layer protein 1 homolog_Q19E_mutation Human genes 0.000 description 1
• 206010047700 Vomiting Diseases 0.000 description 1
• JCZSFCLRSONYLH-UHFFFAOYSA-N Wyosine Natural products N=1C(C)=CN(C(C=2N=C3)=O)C=1N(C)C=2N3C1OC(CO)C(O)C1O JCZSFCLRSONYLH-UHFFFAOYSA-N 0.000 description 1
• 241001441550 Zeiformes Species 0.000 description 1
• JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 1
• TVGUROHJABCRTB-MHJQXXNXSA-N [(2r,3s,4r,5s)-5-[(2r,3r,4r,5r)-2-(2-amino-6-oxo-3h-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound O([C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C=NC=2C(=O)N=C(NC=21)N)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O TVGUROHJABCRTB-MHJQXXNXSA-N 0.000 description 1
• ISXSJGHXHUZXNF-LXZPIJOJSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate;hydrochloride Chemical compound Cl.C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 ISXSJGHXHUZXNF-LXZPIJOJSA-N 0.000 description 1
• TTWXVHUYMARJHI-KWXKLSQISA-N [(6Z,9Z,29Z,32Z)-20-[(dimethylamino)methyl]octatriaconta-6,9,29,32-tetraen-19-yl] carbamate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(CN(C)C)C(OC(N)=O)CCCCCCCC\C=C/C\C=C/CCCCC TTWXVHUYMARJHI-KWXKLSQISA-N 0.000 description 1
• YWBULOYFCXZCGF-UHFFFAOYSA-N [1,3]thiazolo[4,5-d]pyrimidine Chemical class C1=NC=C2SC=NC2=N1 YWBULOYFCXZCGF-UHFFFAOYSA-N 0.000 description 1
• SBCVJZHHHVYKNM-UHFFFAOYSA-M [2-[bis(2-tetradecanoyloxyethyl)amino]-2-oxoethyl]-(2-hydroxyethyl)-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC(=O)OCCN(C(=O)C[N+](C)(C)CCO)CCOC(=O)CCCCCCCCCCCCC SBCVJZHHHVYKNM-UHFFFAOYSA-M 0.000 description 1
• HCAJCMUKLZSPFT-KWXKLSQISA-N [3-(dimethylamino)-2-[(9z,12z)-octadeca-9,12-dienoyl]oxypropyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC HCAJCMUKLZSPFT-KWXKLSQISA-N 0.000 description 1
• NYDLOCKCVISJKK-WRBBJXAJSA-N [3-(dimethylamino)-2-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC NYDLOCKCVISJKK-WRBBJXAJSA-N 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• ZFFZMGJMZGAGMF-SXAUZNKPSA-N [7-[4-(dipropylamino)butyl]-7-hydroxy-13-[(Z)-octadec-9-enoyl]oxytridecyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCC(O)(CCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC)CCCCN(CCC)CCC ZFFZMGJMZGAGMF-SXAUZNKPSA-N 0.000 description 1
• BWQWDZDWUKXQAF-UHFFFAOYSA-N [Cl-].C(CCCCCCCCCCCCCCCCC)[NH+](CC(O)O)CCCCCCCCCCCCCCCCCC Chemical compound [Cl-].C(CCCCCCCCCCCCCCCCC)[NH+](CC(O)O)CCCCCCCCCCCCCCCCCC BWQWDZDWUKXQAF-UHFFFAOYSA-N 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 229960000583 acetic acid Drugs 0.000 description 1
• 235000011054 acetic acid Nutrition 0.000 description 1
• WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
• 150000003838 adenosines Chemical class 0.000 description 1
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 235000019666 ageusia Nutrition 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 125000002947 alkylene group Chemical group 0.000 description 1
• 125000002714 alpha-linolenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000002431 aminoalkoxy group Chemical group 0.000 description 1
• 125000004103 aminoalkyl group Chemical group 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 239000000908 ammonium hydroxide Substances 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• 238000005349 anion exchange Methods 0.000 description 1
• MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 210000001742 aqueous humor Anatomy 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• PEMQXWCOMFJRLS-RPKMEZRRSA-N archaeosine Chemical compound C1=2NC(N)=NC(=O)C=2C(C(=N)N)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O PEMQXWCOMFJRLS-RPKMEZRRSA-N 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 210000003567 ascitic fluid Anatomy 0.000 description 1
• 229960002756 azacitidine Drugs 0.000 description 1
• 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 description 1
• 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 229940050390 benzoate Drugs 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 239000000090 biomarker Substances 0.000 description 1
• 230000006287 biotinylation Effects 0.000 description 1
• 238000007413 biotinylation Methods 0.000 description 1
• 210000004952 blastocoel Anatomy 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 208000027499 body ache Diseases 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 101150013240 bpt gene Proteins 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 150000003842 bromide salts Chemical class 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
• 238000001818 capillary gel electrophoresis Methods 0.000 description 1
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
• MPBRYMWMMKKRGC-UHFFFAOYSA-M carbocyanin DBTC Chemical compound [Br-].C1=CC=CC2=C([N+](=C(C=C(C)C=C3N(C4=C5C=CC=CC5=CC=C4S3)CC)S3)CC)C3=CC=C21 MPBRYMWMMKKRGC-UHFFFAOYSA-M 0.000 description 1
• 229940044199 carnosine Drugs 0.000 description 1
• CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 229930183167 cerebroside Natural products 0.000 description 1
• RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
• 210000002939 cerumen Anatomy 0.000 description 1
• 210000003756 cervix mucus Anatomy 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 125000001309 chloro group Chemical group Cl* 0.000 description 1
• 210000001268 chyle Anatomy 0.000 description 1
• 210000004913 chyme Anatomy 0.000 description 1
• 238000003501 co-culture Methods 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 208000027744 congestion Diseases 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 239000011258 core-shell material Substances 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 125000000000 cycloalkoxy group Chemical group 0.000 description 1
• 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
• 210000002726 cyst fluid Anatomy 0.000 description 1
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
• 238000004163 cytometry Methods 0.000 description 1
• 230000009849 deactivation Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 229940124447 delivery agent Drugs 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 238000011026 diafiltration Methods 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
• UAKOZKUVZRMOFN-JDVCJPALSA-M dimethyl-bis[(z)-octadec-9-enyl]azanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CCCCCCCC\C=C/CCCCCCCC UAKOZKUVZRMOFN-JDVCJPALSA-M 0.000 description 1
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
• SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 125000000107 disulfanyl group Chemical group [*]SS[H] 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000003511 endothelial effect Effects 0.000 description 1
• 210000003038 endothelium Anatomy 0.000 description 1
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 1
• RRCFLRBBBFZLSB-XIFYLAFSSA-N epoxyqueuosine Chemical compound C1=C(CN[C@@H]2[C@H]([C@@H](O)[C@@H]3O[C@@H]32)O)C=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RRCFLRBBBFZLSB-XIFYLAFSSA-N 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• PNZDZRMOBIIQTC-UHFFFAOYSA-N ethanamine;hydron;bromide Chemical compound Br.CCN PNZDZRMOBIIQTC-UHFFFAOYSA-N 0.000 description 1
• JGENYNHRIOHZOP-UHFFFAOYSA-N ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCOP([O-])(=O)OCC[N+](C)(C)C JGENYNHRIOHZOP-UHFFFAOYSA-N 0.000 description 1
• 230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 210000003722 extracellular fluid Anatomy 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 206010016256 fatigue Diseases 0.000 description 1
• 210000004700 fetal blood Anatomy 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 239000013022 formulation composition Substances 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
• 125000003827 glycol group Chemical group 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
• 210000004209 hair Anatomy 0.000 description 1
• 231100000869 headache Toxicity 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• OAMFFXYYHGUAEQ-UHFFFAOYSA-N henicosan-10-amine Chemical compound CCCCCCCCCCCC(N)CCCCCCCCC OAMFFXYYHGUAEQ-UHFFFAOYSA-N 0.000 description 1
• 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• MHRITDAIAZETRS-UHFFFAOYSA-N hexadecan-8-amine Chemical compound CCCCCCCCC(N)CCCCCCC MHRITDAIAZETRS-UHFFFAOYSA-N 0.000 description 1
• KLHSDMQFUVANEB-MELZOAELSA-L hexadecyl-[(2r,3r)-4-[hexadecyl(dimethyl)azaniumyl]-2,3-dimethoxybutyl]-dimethylazanium;dibromide Chemical compound [Br-].[Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C[C@@H](OC)[C@H](OC)C[N+](C)(C)CCCCCCCCCCCCCCCC KLHSDMQFUVANEB-MELZOAELSA-L 0.000 description 1
• 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 235000020256 human milk Nutrition 0.000 description 1
• 210000004251 human milk Anatomy 0.000 description 1
• 229940099552 hyaluronan Drugs 0.000 description 1
• 229920002674 hyaluronan Polymers 0.000 description 1
• KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• 150000002430 hydrocarbons Chemical group 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000012151 immunohistochemical method Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000001524 infective effect Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 238000011031 large-scale manufacturing process Methods 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
• 108010051201 lipid I Proteins 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• KEMQGTRYUADPNZ-UHFFFAOYSA-M margarate Chemical compound CCCCCCCCCCCCCCCCC([O-])=O KEMQGTRYUADPNZ-UHFFFAOYSA-M 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 238000013178 mathematical model Methods 0.000 description 1
• 210000004914 menses Anatomy 0.000 description 1
• GWKIZNPISGBQGY-GNLDREGESA-N methyl (2S)-4-[4,6-dimethyl-9-oxo-3-[(2R,3R,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[1,2-a]purin-7-yl]-2-(methoxycarbonylamino)butanoate Chemical class O[C@@]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(=O)N3C(CC[C@@H](C(=O)OC)NC(=O)OC)=C(C)N=C3N(C)C21 GWKIZNPISGBQGY-GNLDREGESA-N 0.000 description 1
• CMXRLRVXNOFOKI-UHFFFAOYSA-N methyl 12-[2-[4-[2-[2-(didodecylamino)ethyl-dodecylamino]ethyl]piperazin-1-yl]ethyl-dodecylamino]dodecanoate Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CCN(CCCCCCCCCCCC)CCN1CCN(CCN(CCCCCCCCCCCC)CCCCCCCCCCCC(=O)OC)CC1 CMXRLRVXNOFOKI-UHFFFAOYSA-N 0.000 description 1
• XOTXNXXJZCFUOA-UGKPPGOTSA-N methyl 2-[1-[(2r,3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-2,4-dioxopyrimidin-5-yl]acetate Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(CC(=O)OC)=C1 XOTXNXXJZCFUOA-UGKPPGOTSA-N 0.000 description 1
• WCNMEQDMUYVWMJ-UHFFFAOYSA-N methyl 4-[3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6-dimethyl-9-oxoimidazo[1,2-a]purin-7-yl]-3-hydroperoxy-2-(methoxycarbonylamino)butanoate Chemical compound C1=NC=2C(=O)N3C(CC(C(NC(=O)OC)C(=O)OC)OO)=C(C)N=C3N(C)C=2N1C1OC(CO)C(O)C1O WCNMEQDMUYVWMJ-UHFFFAOYSA-N 0.000 description 1
• WZRYXYRWFAPPBJ-PNHWDRBUSA-N methyl uridin-5-yloxyacetate Chemical compound O=C1NC(=O)C(OCC(=O)OC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 WZRYXYRWFAPPBJ-PNHWDRBUSA-N 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 101150084874 mimG gene Proteins 0.000 description 1
• 238000009126 molecular therapy Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• VHRYAHCCVUHIBM-NSOMFCEZSA-N n,n-dimethyl-1,2-bis[(6z,9z,12z)-octadeca-6,9,12-trienoxy]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCOC(C)C(N(C)C)OCCCCC\C=C/C\C=C/C\C=C/CCCCC VHRYAHCCVUHIBM-NSOMFCEZSA-N 0.000 description 1
• XVUQPECVOGMPRU-ZPPAUJSGSA-N n,n-dimethyl-1,2-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOC(C)C(N(C)C)OCCCCCCCC\C=C/C\C=C/CCCCC XVUQPECVOGMPRU-ZPPAUJSGSA-N 0.000 description 1
• MAFHEURJBRFHIT-YEUCEMRASA-N n,n-dimethyl-1,2-bis[(z)-octadec-9-enoxy]propan-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(C)C(N(C)C)OCCCCCCCC\C=C/CCCCCCCC MAFHEURJBRFHIT-YEUCEMRASA-N 0.000 description 1
• UKXOXMLXFQEEQJ-KWXKLSQISA-N n,n-dimethyl-2,3-bis[[(9z,12z)-octadeca-9,12-dienyl]sulfanyl]propan-1-amine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCSCC(CN(C)C)SCCCCCCCC\C=C/C\C=C/CCCCC UKXOXMLXFQEEQJ-KWXKLSQISA-N 0.000 description 1
• FZZRQGRMBHTCSF-UHFFFAOYSA-N n,n-dimethylheptacosan-10-amine Chemical compound CCCCCCCCCCCCCCCCCC(N(C)C)CCCCCCCCC FZZRQGRMBHTCSF-UHFFFAOYSA-N 0.000 description 1
• YVWPBXGPSUWRMH-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4,5-bis(dodecylsulfanyl)pentanamide Chemical compound CCCCCCCCCCCCSCC(CCC(=O)NCCN(C)C)SCCCCCCCCCCCC YVWPBXGPSUWRMH-UHFFFAOYSA-N 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• DEKCSXCNXGALFT-UHFFFAOYSA-N nonadecan-10-amine Chemical compound CCCCCCCCCC(N)CCCCCCCCC DEKCSXCNXGALFT-UHFFFAOYSA-N 0.000 description 1
• 230000030147 nuclear export Effects 0.000 description 1
• 238000001668 nucleic acid synthesis Methods 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 1
• 125000004430 oxygen atom Chemical group O* 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 210000001819 pancreatic juice Anatomy 0.000 description 1
• 230000007918 pathogenicity Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• NTPSQPZXFVRULZ-UHFFFAOYSA-N pentadecan-8-amine Chemical compound CCCCCCCC(N)CCCCCCC NTPSQPZXFVRULZ-UHFFFAOYSA-N 0.000 description 1
• 210000004912 pericardial fluid Anatomy 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
• 150000008105 phosphatidylcholines Chemical class 0.000 description 1
• 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical group NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 150000008299 phosphorodiamidates Chemical class 0.000 description 1
• 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
• 229940068196 placebo Drugs 0.000 description 1
• 239000000902 placebo Substances 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 210000004910 pleural fluid Anatomy 0.000 description 1
• 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 108010011110 polyarginine Proteins 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 108010055896 polyornithine Proteins 0.000 description 1
• 229920002714 polyornithine Polymers 0.000 description 1
• 231100000683 possible toxicity Toxicity 0.000 description 1
• 244000144977 poultry Species 0.000 description 1
• 235000013594 poultry meat Nutrition 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 229960002429 proline Drugs 0.000 description 1
• SDRUOGAFMUPTQU-UHFFFAOYSA-N propyl 2-(dimethylamino)acetate Chemical compound CCCOC(=O)CN(C)C SDRUOGAFMUPTQU-UHFFFAOYSA-N 0.000 description 1
• 125000006308 propyl amino group Chemical group 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 210000004908 prostatic fluid Anatomy 0.000 description 1
• 229940048914 protamine Drugs 0.000 description 1
• 125000006239 protecting group Chemical group 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 1
• 210000004915 pus Anatomy 0.000 description 1
• 150000003216 pyrazines Chemical class 0.000 description 1
• FICMSTTYJICTDM-UHFFFAOYSA-N pyridazine;triazine Chemical compound C1=CC=NN=C1.C1=CN=NN=C1 FICMSTTYJICTDM-UHFFFAOYSA-N 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• QQXQGKSPIMGUIZ-AEZJAUAXSA-N queuosine Chemical compound C1=2C(=O)NC(N)=NC=2N([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=C1CN[C@H]1C=C[C@H](O)[C@@H]1O QQXQGKSPIMGUIZ-AEZJAUAXSA-N 0.000 description 1
• 239000000376 reactant Substances 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 239000003161 ribonuclease inhibitor Substances 0.000 description 1
• DWRXFEITVBNRMK-JXOAFFINSA-N ribothymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DWRXFEITVBNRMK-JXOAFFINSA-N 0.000 description 1
• 238000007157 ring contraction reaction Methods 0.000 description 1
• 238000006049 ring expansion reaction Methods 0.000 description 1
• 102220246998 rs144776609 Human genes 0.000 description 1
• 102220313588 rs376510300 Human genes 0.000 description 1
• 102220045931 rs587782500 Human genes 0.000 description 1
• 102220088189 rs773831600 Human genes 0.000 description 1
• 102220059328 rs786202822 Human genes 0.000 description 1
• 102200108228 rs876658902 Human genes 0.000 description 1
• 102220103310 rs878854070 Human genes 0.000 description 1
• 102200024304 rs886037751 Human genes 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 210000002374 sebum Anatomy 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• JRPHGDYSKGJTKZ-UHFFFAOYSA-N selenophosphoric acid Chemical class OP(O)([SeH])=O JRPHGDYSKGJTKZ-UHFFFAOYSA-N 0.000 description 1
• 238000001338 self-assembly Methods 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 238000007493 shaping process Methods 0.000 description 1
• 208000013220 shortness of breath Diseases 0.000 description 1
• 229910000077 silane Inorganic materials 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 229940126586 small molecule drug Drugs 0.000 description 1
• 210000004988 splenocyte Anatomy 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 108020001568 subdomains Proteins 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 210000004243 sweat Anatomy 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 238000012385 systemic delivery Methods 0.000 description 1
• 210000000538 tail Anatomy 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• XEVMVGUAJRGPOM-UHFFFAOYSA-N tetradecan-5-amine Chemical compound CCCCCCCCCC(N)CCCC XEVMVGUAJRGPOM-UHFFFAOYSA-N 0.000 description 1
• 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 239000005450 thionucleoside Substances 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• ZXXHEYQNCDMMSZ-UHFFFAOYSA-N tridecyl octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCOC(=O)CCCCCCCC=CCC=CCCCCC ZXXHEYQNCDMMSZ-UHFFFAOYSA-N 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• 230000010415 tropism Effects 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 108010087967 type I signal peptidase Proteins 0.000 description 1
• 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
• RVCNQQGZJWVLIP-VPCXQMTMSA-N uridin-5-yloxyacetic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(OCC(O)=O)=C1 RVCNQQGZJWVLIP-VPCXQMTMSA-N 0.000 description 1
• YIZYCHKPHCPKHZ-UHFFFAOYSA-N uridine-5-acetic acid methyl ester Natural products COC(=O)Cc1cn(C2OC(CO)C(O)C2O)c(=O)[nH]c1=O YIZYCHKPHCPKHZ-UHFFFAOYSA-N 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• 230000007332 vesicle formation Effects 0.000 description 1
• 230000007502 viral entry Effects 0.000 description 1
• 230000017613 viral reproduction Effects 0.000 description 1
• 210000004916 vomit Anatomy 0.000 description 1
• QAOHCFGKCWTBGC-QHOAOGIMSA-N wybutosine Chemical compound C1=NC=2C(=O)N3C(CC[C@H](NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QAOHCFGKCWTBGC-QHOAOGIMSA-N 0.000 description 1
• QAOHCFGKCWTBGC-UHFFFAOYSA-N wybutosine Natural products C1=NC=2C(=O)N3C(CCC(NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1C1OC(CO)C(O)C1O QAOHCFGKCWTBGC-UHFFFAOYSA-N 0.000 description 1
• JCZSFCLRSONYLH-QYVSTXNMSA-N wyosin Chemical compound N=1C(C)=CN(C(C=2N=C3)=O)C=1N(C)C=2N3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JCZSFCLRSONYLH-QYVSTXNMSA-N 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1
• RPQZTTQVRYEKCR-WCTZXXKLSA-N zebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=CC=C1 RPQZTTQVRYEKCR-WCTZXXKLSA-N 0.000 description 1